00010322209/302020Q2FALSEP1YP5Y00010322202019-10-012020-03-31xbrli:shares00010322202020-05-04iso4217:USD00010322202020-01-012020-03-3100010322202019-01-012019-03-3100010322202018-10-012019-03-31iso4217:USDxbrli:shares00010322202020-03-3100010322202019-09-3000010322202018-09-3000010322202019-03-310001032220us-gaap:CommonStockMember2019-12-310001032220us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-12-310001032220us-gaap:RetainedEarningsMember2019-12-3100010322202019-12-310001032220us-gaap:RetainedEarningsMember2020-01-012020-03-310001032220us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-01-012020-03-310001032220us-gaap:CommonStockMember2020-01-012020-03-310001032220us-gaap:CommonStockMember2020-03-310001032220us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-03-310001032220us-gaap:RetainedEarningsMember2020-03-310001032220us-gaap:CommonStockMember2019-09-300001032220us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-09-300001032220us-gaap:RetainedEarningsMember2019-09-300001032220us-gaap:NoncontrollingInterestMember2019-09-300001032220us-gaap:RetainedEarningsMember2019-10-012020-03-310001032220us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-10-012020-03-310001032220us-gaap:NoncontrollingInterestMember2019-10-012020-03-310001032220us-gaap:CommonStockMember2019-10-012020-03-310001032220us-gaap:NoncontrollingInterestMember2020-03-310001032220us-gaap:CommonStockMember2018-12-310001032220us-gaap:AccumulatedOtherComprehensiveIncomeMember2018-12-310001032220us-gaap:RetainedEarningsMember2018-12-310001032220us-gaap:NoncontrollingInterestMember2018-12-3100010322202018-12-310001032220us-gaap:RetainedEarningsMember2019-01-012019-03-310001032220us-gaap:NoncontrollingInterestMember2019-01-012019-03-310001032220us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-01-012019-03-310001032220us-gaap:CommonStockMember2019-01-012019-03-310001032220us-gaap:CommonStockMember2019-03-310001032220us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-03-310001032220us-gaap:RetainedEarningsMember2019-03-310001032220us-gaap:NoncontrollingInterestMember2019-03-310001032220us-gaap:CommonStockMember2018-09-300001032220us-gaap:AccumulatedOtherComprehensiveIncomeMember2018-09-300001032220us-gaap:RetainedEarningsMember2018-09-300001032220us-gaap:NoncontrollingInterestMember2018-09-300001032220us-gaap:RetainedEarningsMember2018-10-010001032220us-gaap:NoncontrollingInterestMember2018-10-0100010322202018-10-010001032220us-gaap:RetainedEarningsMember2018-10-012019-03-310001032220us-gaap:NoncontrollingInterestMember2018-10-012019-03-310001032220us-gaap:AccumulatedOtherComprehensiveIncomeMember2018-10-012019-03-310001032220us-gaap:CommonStockMember2018-10-012019-03-31mms:segment0001032220us-gaap:AccountingStandardsUpdate201602Member2019-10-0100010322202019-10-010001032220us-gaap:OperatingSegmentsMembermms:USHealthAndHumanServicesMember2020-01-012020-03-310001032220us-gaap:OperatingSegmentsMembermms:USHealthAndHumanServicesMember2019-01-012019-03-310001032220us-gaap:OperatingSegmentsMembermms:USHealthAndHumanServicesMember2019-10-012020-03-310001032220us-gaap:OperatingSegmentsMembermms:USHealthAndHumanServicesMember2018-10-012019-03-310001032220us-gaap:OperatingSegmentsMembermms:U.S.FederalServicesMember2020-01-012020-03-310001032220us-gaap:OperatingSegmentsMembermms:U.S.FederalServicesMember2019-01-012019-03-310001032220us-gaap:OperatingSegmentsMembermms:U.S.FederalServicesMember2019-10-012020-03-310001032220us-gaap:OperatingSegmentsMembermms:U.S.FederalServicesMember2018-10-012019-03-310001032220us-gaap:OperatingSegmentsMembermms:OutsideTheUnitedStatesMember2020-01-012020-03-310001032220us-gaap:OperatingSegmentsMembermms:OutsideTheUnitedStatesMember2019-01-012019-03-310001032220us-gaap:OperatingSegmentsMembermms:OutsideTheUnitedStatesMember2019-10-012020-03-310001032220us-gaap:OperatingSegmentsMembermms:OutsideTheUnitedStatesMember2018-10-012019-03-31xbrli:pure0001032220us-gaap:MaterialReconcilingItemsMember2020-01-012020-03-310001032220us-gaap:MaterialReconcilingItemsMember2019-01-012019-03-310001032220us-gaap:MaterialReconcilingItemsMember2019-10-012020-03-310001032220us-gaap:MaterialReconcilingItemsMember2018-10-012019-03-310001032220us-gaap:OperatingSegmentsMembermms:USHealthAndHumanServicesMember2020-03-310001032220us-gaap:OperatingSegmentsMembermms:USHealthAndHumanServicesMember2019-09-300001032220us-gaap:OperatingSegmentsMembermms:U.S.FederalServicesMember2020-03-310001032220us-gaap:OperatingSegmentsMembermms:U.S.FederalServicesMember2019-09-300001032220us-gaap:OperatingSegmentsMembermms:OutsideTheUnitedStatesMember2020-03-310001032220us-gaap:OperatingSegmentsMembermms:OutsideTheUnitedStatesMember2019-09-300001032220us-gaap:CorporateNonSegmentMember2020-03-310001032220us-gaap:CorporateNonSegmentMember2019-09-300001032220us-gaap:BuildingMember2020-03-310001032220us-gaap:EquipmentMember2020-03-310001032220mms:ProgramAdministrationMembermms:USHealthAndHumanServicesMember2020-01-012020-03-310001032220mms:ProgramAdministrationMembermms:USHealthAndHumanServicesMember2019-01-012019-03-310001032220mms:ProgramAdministrationMembermms:USHealthAndHumanServicesMember2019-10-012020-03-310001032220mms:ProgramAdministrationMembermms:USHealthAndHumanServicesMember2018-10-012019-03-310001032220mms:AssessmentsAndAppealsMembermms:USHealthAndHumanServicesMember2020-01-012020-03-310001032220mms:AssessmentsAndAppealsMembermms:USHealthAndHumanServicesMember2019-01-012019-03-310001032220mms:AssessmentsAndAppealsMembermms:USHealthAndHumanServicesMember2019-10-012020-03-310001032220mms:AssessmentsAndAppealsMembermms:USHealthAndHumanServicesMember2018-10-012019-03-310001032220mms:WorkforceAndChildrenServicesMembermms:USHealthAndHumanServicesMember2020-01-012020-03-310001032220mms:WorkforceAndChildrenServicesMembermms:USHealthAndHumanServicesMember2019-01-012019-03-310001032220mms:WorkforceAndChildrenServicesMembermms:USHealthAndHumanServicesMember2019-10-012020-03-310001032220mms:WorkforceAndChildrenServicesMembermms:USHealthAndHumanServicesMember2018-10-012019-03-310001032220mms:OtherMembermms:USHealthAndHumanServicesMember2020-01-012020-03-310001032220mms:OtherMembermms:USHealthAndHumanServicesMember2019-01-012019-03-310001032220mms:OtherMembermms:USHealthAndHumanServicesMember2019-10-012020-03-310001032220mms:OtherMembermms:USHealthAndHumanServicesMember2018-10-012019-03-310001032220mms:USHealthAndHumanServicesMember2020-01-012020-03-310001032220mms:USHealthAndHumanServicesMember2019-01-012019-03-310001032220mms:USHealthAndHumanServicesMember2019-10-012020-03-310001032220mms:USHealthAndHumanServicesMember2018-10-012019-03-310001032220mms:U.S.FederalServicesMembermms:ProgramAdministrationMember2020-01-012020-03-310001032220mms:U.S.FederalServicesMembermms:ProgramAdministrationMember2019-01-012019-03-310001032220mms:U.S.FederalServicesMembermms:ProgramAdministrationMember2019-10-012020-03-310001032220mms:U.S.FederalServicesMembermms:ProgramAdministrationMember2018-10-012019-03-310001032220mms:U.S.FederalServicesMembermms:TechnologySolutionsMember2020-01-012020-03-310001032220mms:U.S.FederalServicesMembermms:TechnologySolutionsMember2019-01-012019-03-310001032220mms:U.S.FederalServicesMembermms:TechnologySolutionsMember2019-10-012020-03-310001032220mms:U.S.FederalServicesMembermms:TechnologySolutionsMember2018-10-012019-03-310001032220mms:U.S.FederalServicesMembermms:AssessmentsAndAppealsMember2020-01-012020-03-310001032220mms:U.S.FederalServicesMembermms:AssessmentsAndAppealsMember2019-01-012019-03-310001032220mms:U.S.FederalServicesMembermms:AssessmentsAndAppealsMember2019-10-012020-03-310001032220mms:U.S.FederalServicesMembermms:AssessmentsAndAppealsMember2018-10-012019-03-310001032220mms:U.S.FederalServicesMember2020-01-012020-03-310001032220mms:U.S.FederalServicesMember2019-01-012019-03-310001032220mms:U.S.FederalServicesMember2019-10-012020-03-310001032220mms:U.S.FederalServicesMember2018-10-012019-03-310001032220mms:OutsideTheUnitedStatesMembermms:WorkforceAndChildrenServicesMember2020-01-012020-03-310001032220mms:OutsideTheUnitedStatesMembermms:WorkforceAndChildrenServicesMember2019-01-012019-03-310001032220mms:OutsideTheUnitedStatesMembermms:WorkforceAndChildrenServicesMember2019-10-012020-03-310001032220mms:OutsideTheUnitedStatesMembermms:WorkforceAndChildrenServicesMember2018-10-012019-03-310001032220mms:OutsideTheUnitedStatesMembermms:AssessmentsAndAppealsMember2020-01-012020-03-310001032220mms:OutsideTheUnitedStatesMembermms:AssessmentsAndAppealsMember2019-01-012019-03-310001032220mms:OutsideTheUnitedStatesMembermms:AssessmentsAndAppealsMember2019-10-012020-03-310001032220mms:OutsideTheUnitedStatesMembermms:AssessmentsAndAppealsMember2018-10-012019-03-310001032220mms:OutsideTheUnitedStatesMembermms:ProgramAdministrationMember2020-01-012020-03-310001032220mms:OutsideTheUnitedStatesMembermms:ProgramAdministrationMember2019-01-012019-03-310001032220mms:OutsideTheUnitedStatesMembermms:ProgramAdministrationMember2019-10-012020-03-310001032220mms:OutsideTheUnitedStatesMembermms:ProgramAdministrationMember2018-10-012019-03-310001032220mms:OutsideTheUnitedStatesMembermms:OtherMember2020-01-012020-03-310001032220mms:OutsideTheUnitedStatesMembermms:OtherMember2019-01-012019-03-310001032220mms:OutsideTheUnitedStatesMembermms:OtherMember2019-10-012020-03-310001032220mms:OutsideTheUnitedStatesMembermms:OtherMember2018-10-012019-03-310001032220mms:OutsideTheUnitedStatesMember2020-01-012020-03-310001032220mms:OutsideTheUnitedStatesMember2019-01-012019-03-310001032220mms:OutsideTheUnitedStatesMember2019-10-012020-03-310001032220mms:OutsideTheUnitedStatesMember2018-10-012019-03-310001032220mms:PerformanceBasedContractsMember2020-01-012020-03-310001032220mms:PerformanceBasedContractsMember2019-01-012019-03-310001032220mms:PerformanceBasedContractsMember2019-10-012020-03-310001032220mms:PerformanceBasedContractsMember2018-10-012019-03-310001032220mms:CostPlusContractsMember2020-01-012020-03-310001032220mms:CostPlusContractsMember2019-01-012019-03-310001032220mms:CostPlusContractsMember2019-10-012020-03-310001032220mms:CostPlusContractsMember2018-10-012019-03-310001032220us-gaap:FixedPriceContractMember2020-01-012020-03-310001032220us-gaap:FixedPriceContractMember2019-01-012019-03-310001032220us-gaap:FixedPriceContractMember2019-10-012020-03-310001032220us-gaap:FixedPriceContractMember2018-10-012019-03-310001032220us-gaap:TimeAndMaterialsContractMember2020-01-012020-03-310001032220us-gaap:TimeAndMaterialsContractMember2019-01-012019-03-310001032220us-gaap:TimeAndMaterialsContractMember2019-10-012020-03-310001032220us-gaap:TimeAndMaterialsContractMember2018-10-012019-03-310001032220mms:NewYorkStateGovernmentAgenciesMember2020-01-012020-03-310001032220mms:NewYorkStateGovernmentAgenciesMember2019-01-012019-03-310001032220mms:NewYorkStateGovernmentAgenciesMember2019-10-012020-03-310001032220mms:NewYorkStateGovernmentAgenciesMember2018-10-012019-03-310001032220mms:OtherUnitedStatesStateGovernmentAgenciesMember2020-01-012020-03-310001032220mms:OtherUnitedStatesStateGovernmentAgenciesMember2019-01-012019-03-310001032220mms:OtherUnitedStatesStateGovernmentAgenciesMember2019-10-012020-03-310001032220mms:OtherUnitedStatesStateGovernmentAgenciesMember2018-10-012019-03-310001032220mms:TotalUnitedStatesStateGovernmentAgenciesMember2020-01-012020-03-310001032220mms:TotalUnitedStatesStateGovernmentAgenciesMember2019-01-012019-03-310001032220mms:TotalUnitedStatesStateGovernmentAgenciesMember2019-10-012020-03-310001032220mms:TotalUnitedStatesStateGovernmentAgenciesMember2018-10-012019-03-310001032220mms:UnitedStatesFederalGovernmentAgenciesMember2020-01-012020-03-310001032220mms:UnitedStatesFederalGovernmentAgenciesMember2019-01-012019-03-310001032220mms:UnitedStatesFederalGovernmentAgenciesMember2019-10-012020-03-310001032220mms:UnitedStatesFederalGovernmentAgenciesMember2018-10-012019-03-310001032220mms:InternationalGovernmentAgenciesMember2020-01-012020-03-310001032220mms:InternationalGovernmentAgenciesMember2019-01-012019-03-310001032220mms:InternationalGovernmentAgenciesMember2019-10-012020-03-310001032220mms:InternationalGovernmentAgenciesMember2018-10-012019-03-310001032220mms:OtherIncludingLocalMunicipalitiesAndCommercialCustomersMember2020-01-012020-03-310001032220mms:OtherIncludingLocalMunicipalitiesAndCommercialCustomersMember2019-01-012019-03-310001032220mms:OtherIncludingLocalMunicipalitiesAndCommercialCustomersMember2019-10-012020-03-310001032220mms:OtherIncludingLocalMunicipalitiesAndCommercialCustomersMember2018-10-012019-03-310001032220country:US2020-01-012020-03-310001032220country:US2019-01-012019-03-310001032220country:US2019-10-012020-03-310001032220country:US2018-10-012019-03-310001032220country:GB2020-01-012020-03-310001032220country:GB2019-01-012019-03-310001032220country:GB2019-10-012020-03-310001032220country:GB2018-10-012019-03-310001032220country:AU2020-01-012020-03-310001032220country:AU2019-01-012019-03-310001032220country:AU2019-10-012020-03-310001032220country:AU2018-10-012019-03-310001032220mms:RestofWorldMember2020-01-012020-03-310001032220mms:RestofWorldMember2019-01-012019-03-310001032220mms:RestofWorldMember2019-10-012020-03-310001032220mms:RestofWorldMember2018-10-012019-03-3100010322202020-04-012020-03-310001032220mms:GeneralDynamicsInformationTechnologysCitizenEngagementCentersMember2018-11-162018-11-160001032220mms:GeneralDynamicsInformationTechnologysCitizenEngagementCentersMember2018-11-160001032220mms:GTHiringSolutionsIncMember2019-08-160001032220mms:GTHiringSolutionsIncMember2019-08-162019-08-16iso4217:CAD0001032220mms:InjuryNetMember2020-02-280001032220mms:InjuryNetMember2020-02-282020-02-28iso4217:AUD0001032220mms:StockRepurchaseProgramMarch2020Memberus-gaap:CommonStockMember2020-03-310001032220us-gaap:RestrictedStockUnitsRSUMember2019-10-012020-03-310001032220us-gaap:RestrictedStockUnitsRSUMembersrt:DirectorMember2019-10-012020-03-3100010322202020-02-290001032220us-gaap:SubsequentEventMember2020-04-032020-04-030001032220srt:ScenarioForecastMember2020-05-292020-05-290001032220us-gaap:SubsequentEventMembermms:Q2AdministratorsLLCMember2020-05-012020-05-01


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 10-Q
(Mark One)
☒ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
For the quarterly period ended March 31, 2020
OR
☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
For the transition period from   to
 
Commission File Number: 1-12997
 
MAXIMUS, INC.
(Exact name of registrant as specified in its charter)
 
Virginia   54-1000588
(State or other jurisdiction of
incorporation or organization) 		  (I.R.S. Employer
Identification No.)
     
1891 Metro Center Drive, Reston, Virginia
  20190
(Address of principal executive offices)   (Zip Code)
 
(703) 251-8500
(Registrant’s telephone number, including area code)
 
Securities registered pursuant to Section 12(b) of the Act:
Title of each class Trading Symbol(s) Name of each exchange on which registered
Common Stock, no par value MMS New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes ☒ No ☐
 
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).  Yes ☒ No ☐
 
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and "emerging growth company" in Rule 12b-2 of the Exchange Act. (Check one):
Large accelerated filer ☒
 
Accelerated filer ☐
     
Non-accelerated filer ☐
 
Smaller reporting company ☐
   
Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  Yes ☐ No ☒
 
As of May 4, 2020, there were 61,312,619 shares of the registrant’s common stock (no par value) outstanding.



MAXIMUS, Inc.
Quarterly Report on Form 10-Q
For the Quarter Ended March 31, 2020
INDEX
PART I. FINANCIAL INFORMATION  
Item 1.
1
   
 
1
   
 
2
   
3
   
 
4
   
 
5
   
 
7
   
Item 2.
18
   
Item 3.
29
   
Item 4.
29
   
PART II. OTHER INFORMATION  
   
Item 1.
30
Item 1A.
30
Item 2.
30
Item 6.
32
   
33



Throughout this Quarterly Report on Form 10-Q, the terms “Company,” “we,” “us,” “our” and “MAXIMUS” refer to MAXIMUS, Inc. and its subsidiaries, unless the context requires otherwise.
SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS
Included in this Quarterly Report on Form 10-Q are forward-looking statements within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by words such as: “anticipate,” “intend,” “plan,” “goal,” “seek,” “opportunity,” “could,” “potential,” “believe,” “project,” “estimate,” “expect,” “strategy,” “future,” “likely,” “may,” “should,” “will” and similar references to future periods.
Forward-looking statements that are not historical facts, including statements about our confidence, strategies and initiatives and our expectations about revenues, results of operations, profitability, liquidity, market demand or the impact of the COVID-19 pandemic are forward-looking statements that involve risks and uncertainties. These risks could cause our actual results to differ materially from those indicated by such forward-looking statements. Therefore, you should not rely on any of these forward-looking statements. Important factors that could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements include, among others, the following:
•the continued spread of the COVID-19 virus, including the speed, depth, geographic reach and duration of the spread, and the actions to be taken by us, our customers and the governments of jurisdictions in which we operate in response to COVID-19;
•the demand for our services and products, including based on any downturns in the economy;
•a failure to meet performance requirements in our contracts, which might lead to contract termination and actual or liquidated damages;
•the effects of future legislative or government budgetary and spending changes;
•our failure to successfully bid for and accurately price contracts to generate our desired profit;
•our ability to maintain technology systems and otherwise protect confidential or protected information;
•our ability to attract and retain executive officers, senior managers and other qualified personnel to execute our business;
•our ability to manage capital investments and startup costs incurred before receiving related contract payments;
•our ability to manage our growth, including acquired businesses;
•the ability of government customers to terminate contracts on short notice, with or without cause;
•our ability to maintain relationships with key government entities from whom a substantial portion of our revenue is derived;
•the outcome of reviews or audits, which might result in financial penalties and impair our ability to respond to invitations for new work;
•a failure to comply with laws governing our business, which might result in the Company being subject to fines, penalties, suspension, debarment and other sanctions;
•the costs and outcome of litigation;
•difficulties in integrating or achieving projected revenues, earnings and other benefits associated with acquired businesses;
•the effects of changes in laws and regulations governing our business, including tax laws, and applicable interpretations and guidance thereunder, or changes in accounting policies, rules, methodologies and practices, and our ability to estimate the impact of such changes;
•matters related to business we have disposed of or divested; and
•other factors set forth in Item 1A of this Quarterly Report on Form 10-Q and in Exhibit 99.1, under the caption "Special Considerations and Risk Factors," in our Annual Report on Form 10-K for the year ended September 30, 2019, which was filed with the Securities and Exchange Commission on November 26, 2019.
Any forward-looking statement made by us in this report is based only on information currently available to us and speaks only as of the date on which it is made. We undertake no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise.


PART I.  FINANCIAL INFORMATION
Item 1. Consolidated Financial Statements.
MAXIMUS, Inc.
CONSOLIDATED STATEMENTS OF OPERATIONS
(Amounts in thousands, except per share data)
(Unaudited)
  Three Months Ended March 31, Six Months Ended March 31,
  2020 2019 2020 2019
Revenue $ 818,135    $ 736,520    $ 1,636,364    $ 1,401,139   
Cost of revenue 665,037    567,098    1,307,816    1,072,452   
Gross profit 153,098    169,422    328,548    328,687   
Selling, general and administrative expenses 106,853    78,102    194,080    157,773   
Amortization of intangible assets 8,934    9,519    18,022    14,977   
Operating income 37,311    81,801    116,446    155,937   
Interest expense 465    1,569    949    2,194   
Other income, net 573    447    1,292    2,492   
Income before income taxes 37,419    80,679    116,789    156,235   
Provision for income taxes 9,769    18,913    30,405    38,746   
Net income 27,650    61,766    86,384    117,489   
Loss attributable to noncontrolling interests —    (158)   —    (348)  
Net income attributable to MAXIMUS $ 27,650    $ 61,924    $ 86,384    $ 117,837   
Basic earnings per share $ 0.43    $ 0.96    $ 1.34    $ 1.82   
Diluted earnings per share $ 0.43    $ 0.96    $ 1.34    $ 1.82   
Dividends paid per share $ 0.28    $ 0.25    $ 0.56    $ 0.50   
Weighted average shares outstanding:    
Basic 63,934    64,369    64,264    64,600   
Diluted 64,125    64,643    64,446    64,817   

See notes to unaudited consolidated financial statements.
1

MAXIMUS, Inc.
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
(Amounts in thousands)
(Unaudited)
  Three Months Ended March 31, Six Months Ended March 31,
  2020 2019 2020 2019
Net income $ 27,650    $ 61,766    $ 86,384    $ 117,489   
Foreign currency translation adjustments (11,629)   3,537    (4,736)   (2,183)  
Comprehensive income 16,021    65,303    81,648    115,306   
Comprehensive loss attributable to noncontrolling interests —    (158)   —    (348)  
Comprehensive income attributable to MAXIMUS $ 16,021    $ 65,461    $ 81,648    $ 115,654   

See notes to unaudited consolidated financial statements.
2

MAXIMUS, Inc.
CONSOLIDATED BALANCE SHEETS
(Amounts in thousands)
 
  March 31,
2020 		September 30,
2019
  (unaudited)  
ASSETS    
Current assets:    
Cash and cash equivalents $ 126,257    $ 105,565   
Accounts receivable — billed and billable, net of reserves of $12,054 and $5,382
529,928    476,690   
Accounts receivable — unbilled 120,159    123,884   
Income taxes receivable 33,852    20,805   
Prepaid expenses and other current assets 53,257    62,481   
Total current assets 863,453    789,425   
Property and equipment, net 80,843    99,589   
Capitalized software, net 33,746    32,369   
Operating lease right-of-use assets 179,701    —   
Goodwill 585,772    584,469   
Intangible assets, net 161,091    179,250   
Deferred contract costs, net 19,278    18,921   
Deferred compensation plan assets 28,016    32,908   
Deferred income taxes 186    186   
Other assets 8,320    8,615   
Total assets $ 1,960,406    $ 1,745,732   
LIABILITIES AND SHAREHOLDERS’ EQUITY    
Current liabilities:    
Accounts payable and accrued liabilities $ 191,505    $ 177,786   
Accrued compensation and benefits 98,882    106,789   
Deferred revenue 46,206    43,344   
Income taxes payable 758    13,952   
Current portion of long-term debt and other borrowings 9,352    9,658   
Operating lease liabilities 78,656    —   
Other liabilities 12,973    12,709   
Total current liabilities 438,332    364,238   
Deferred revenue, less current portion 34,142    32,341   
Deferred income taxes 49,421    46,560   
Long-term debt, less current portion 150,155    231   
Deferred compensation plan liabilities, less current portion 30,431    34,079   
Operating lease liabilities, less current portion 109,339    —   
Other liabilities 10,118    20,082   
Total liabilities 821,938    497,531   
Shareholders’ equity:    
Common stock, no par value; 100,000 shares authorized; 61,313 and 63,979 shares issued and outstanding at March 31, 2020, and September 30, 2019, at stated amount, respectively
511,023    498,433   
Accumulated other comprehensive loss (50,116)   (45,380)  
Retained earnings 677,561    794,739   
Total MAXIMUS shareholders' equity 1,138,468    1,247,792   
Noncontrolling interests —    409   
Total equity 1,138,468    1,248,201   
Total liabilities and equity $ 1,960,406    $ 1,745,732   
 
See notes to unaudited consolidated financial statements.
3

MAXIMUS, Inc.
CONSOLIDATED STATEMENTS OF CASH FLOWS
(Amounts in thousands)
(Unaudited)
  Six Months Ended March 31,
  2020 2019
Cash flows from operations:    
Net income $ 86,384    $ 117,489   
Adjustments to reconcile net income to cash flows from operations:    
Depreciation and amortization of property and equipment and
capitalized software 		31,218    22,407   
Amortization of intangible assets 18,022    14,977   
Deferred income taxes 3,038    17,764   
Stock compensation expense 11,800    9,904   
Change in assets and liabilities net of effects of business combinations    
Accounts receivable — billed and billable (52,870)   (72,720)  
Accounts receivable — unbilled 2,289    9,189   
Prepaid expenses and other current assets 4,262    (5,118)  
Deferred contract costs (497)   (5,415)  
Accounts payable and accrued liabilities 22,322    42,080   
Accrued compensation and benefits 3,839    (7,443)  
Deferred revenue 5,300    4,435   
Income taxes (27,706)   (16,496)  
Operating lease right-of-use assets and liabilities 166    —   
Other assets and liabilities 1,705    (3,842)  
Cash flows from operations 109,272    127,211   
Cash flows from investing activities:    
Purchases of property and equipment and capitalized software costs (19,122)   (18,541)  
Acquisitions of businesses, net of cash acquired (2,551)   (421,809)  
Maturities of short-term investments —    19,996   
Other 98    284   
Cash used in investing activities (21,575)   (420,070)  
Cash flows from financing activities:    
Cash dividends paid to MAXIMUS shareholders (35,813)   (31,983)  
Purchases of MAXIMUS common stock (166,959)   (46,068)  
Tax withholding related to RSU vesting (10,614)   (8,915)  
Borrowings under credit facility and other loan agreements 341,715    320,048   
Repayment of credit facility and other long-term debt (191,256)   (241,539)  
Other (652)   (133)  
Cash used in financing activities (63,579)   (8,590)  
Effect of exchange rate changes on cash and cash equivalents (1,868)   (632)  
Net increase/(decrease) in cash, cash equivalents and restricted cash 22,250    (302,081)  
Cash, cash equivalents and restricted cash, beginning of period 116,492    356,559   
Cash, cash equivalents and restricted cash, end of period $ 138,742    $ 54,478   

See notes to unaudited consolidated financial statements.
4

MAXIMUS, Inc.
CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY
(Amounts in thousands)
(Unaudited)
 
  Common
Shares
Outstanding 		Common
Stock 		Accumulated
Other
Comprehensive
Loss 		Retained
Earnings 		Noncontrolling
Interest 		Total
Balance at December 31, 2019 63,953    $ 504,184    $ (38,487)   $ 833,308    $ —    $ 1,299,005   
Net income —    —    —    27,650    —    27,650   
Foreign currency translation —    —    (11,629)   —    —    (11,629)  
Cash dividends —    —    —    (17,900)   —    (17,900)  
Dividends on RSUs —    436    —    (436)   —    —   
Purchases of MAXIMUS common stock (2,741)   —    —    (165,061)   —    (165,061)  
Stock compensation expense —    6,403    —    —    —    6,403   
RSUs vested 101    —    —    —    —    —   
Balance at March 31, 2020 61,313    $ 511,023    $ (50,116)   $ 677,561    $ —    $ 1,138,468   

 
Common
Shares
Outstanding 		Common
Stock 		Accumulated
Other
Comprehensive
Loss 		Retained
Earnings 		Noncontrolling interest Total
Balance at September 30, 2019 63,979    $ 498,433    $ (45,380)   $ 794,739    $ 409    $ 1,248,201   
Net income —    —    —    86,384    —    86,384   
Foreign currency translation —    —    (4,736)   —    —    (4,736)  
Cash dividends —    —    —    (35,813)   (409)   (36,222)  
Dividends on RSUs —    790    —    (790)   —    —   
Purchases of MAXIMUS common stock (2,767)   —    —    (166,959)   —    (166,959)  
Stock compensation expense —    11,800    —    —    —    11,800   
RSUs vested 101    —    —    —    —   
Balance at March 31, 2020 61,313    $ 511,023    $ (50,116)   $ 677,561    $ —    $ 1,138,468   









5



MAXIMUS, Inc.
CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY
(Amounts in thousands)
(Unaudited)
Common
Shares
Outstanding 		Common
Stock 		Accumulated
Other
Comprehensive
Loss 		Retained
Earnings 		Noncontrolling
Interest 		Total
Balance at December 31, 2018 63,717    492,938    (42,673)   664,332    2,782    1,117,379   
Net income —    —    —    61,924    (158)   61,766   
Foreign currency translation —    —    3,537    —    —    3,537   
Cash dividends —    —    —    (15,950)   —    (15,950)  
Dividends on RSUs —    398    —    (398)   —    —   
Purchases of MAXIMUS common stock (62)   —    —    (4,084)   —    (4,084)  
Stock compensation expense —    4,933    —    —    —    4,933   
RSUs vested 156    —    —    —    —    —   
Balance at March 31, 2019 63,811    498,269    (39,136)   705,824    2,624    1,167,581   


Common
Shares
Outstanding 		Common
Stock 		Accumulated
Other
Comprehensive
Loss 		Retained
Earnings 		Noncontrolling
Interest 		Total
Balance at September 30, 2018 64,371    487,539    (36,953)   633,281    2,552    1,086,419   
Cumulative impact from adopting ASC Topic 606 on October 1, 2018 —    —    —    32,929    553    33,482   
Net income —    —    —    117,837    (348)   117,489   
Foreign currency translation —    —    (2,183)   —    —    (2,183)  
Cash dividends —    —    —    (31,983)   (133)   (32,116)  
Dividends on RSUs —    826    —    (826)   —    —   
Purchases of MAXIMUS common stock (716)   —    —    (45,414)   —    (45,414)  
Stock compensation expense —    9,904    —    —    —    9,904   
RSUs vested 156    —    —    —    —    —   
Balance at March 31, 2019 $ 63,811    $ 498,269    $ (39,136)   $ 705,824    $ 2,624    $ 1,167,581   








See notes to unaudited consolidated financial statements.
6


MAXIMUS, Inc.
Notes to Unaudited Consolidated Financial Statements
For the Three and Six Months Ended March 31, 2020 and 2019

1. Organization and Basis of Presentation
The accompanying unaudited consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States for interim financial information and the instructions to Form 10-Q and Article 10 of Regulation S-X. As permitted by these instructions, they do not include all of the information and notes required by generally accepted accounting principles (GAAP) for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for a fair presentation have been included. All intercompany balances and transactions have been eliminated in consolidation. The results of operations for the three and six months ended March 31, 2020, are not necessarily indicative of the results that may be expected for the full fiscal year. The balance sheet at September 30, 2019, has been derived from the audited financial statements at that date, but does not include all of the information and notes required by GAAP for complete financial statements.
These financial statements should be read in conjunction with the consolidated audited financial statements and the notes thereto at September 30, 2019 and 2018, and for each of the three years ended September 30, 2019, included in our Annual Report on Form 10-K which was filed with the Securities and Exchange Commission on November 26, 2019.
Estimates
The preparation of these financial statements requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent liabilities and the reported amounts of revenue and expenses. At each reporting period end, we make estimates including those related to revenue recognition and cost estimation on certain contracts, the realizability of goodwill and amounts related to income taxes, certain accrued liabilities and contingencies and litigation.
We base our estimates on historical experience and expectations of the future that we believe to be reasonable. The economic and political impacts of the COVID-19 pandemic increases uncertainty, which has reduced our ability to use past results to estimate future performance. Accordingly, our estimates may be subject to greater volatility than has been the case in the past.
•Our balance sheet includes goodwill valued at $585.8 million. This balance is allocated between reporting units, which are consistent with our three operating segments. Goodwill is not amortized but is tested for impairment when necessary and no less than once per year. We performed our last annual goodwill impairment test as of July 1, 2019. As of July 1, 2019, none of our reporting units showed any signs of impairment and all held a fair value estimated to be at least twice as high as their carrying value. We continue to monitor the fair value of our reporting units and, at this time, we do not believe any goodwill impairment has occurred. This is based upon a number of factors, including the long-term viability of our business and the creditworthiness of our customer base.
•Our balance sheet includes a number of long-lived assets, including property and equipment, capitalized software, operating lease right-of-use assets, deferred contract costs and intangible assets. These assets are depreciated or amortized over their estimated useful economic lives but are subject to impairment if events indicate that the carrying amount may not be recoverable. At this time, there are no significant balances which we believe are not recoverable.
•Our balance sheet includes $650.1 million of billed, billable and unbilled accounts receivable, net of reserves. We regularly evaluate this balance for recoverability and reserve those balances where we no longer believe that collection is probable. Bad debt expense has not historically been significant to our business due to the nature of our customers. During the three months ended March 31, 2020, we recorded bad debt expense of $7.8 million. We have reserved balances against customers who we believe are experiencing difficulties during the COVID-19 pandemic and may not be able to reimburse us for work performed.
•As disclosed in "Note 4. Revenue Recognition", revenue for some our welfare-to-work contracts in the Outside the U.S. Segment is based upon achievement of future outcomes as defined in each contract. Specifically, we are paid as individuals attain employment goals, which may take many months to achieve. Revenue is recognized on these contracts over the period of performance. Employment markets worldwide
7

have suffered a significant shock during the three months ended March 31, 2020 and many employment opportunities have been terminated or are no longer available. While we expect the volume of new program participants to increase as a result of disruption to employment markets, we believe that our program outcomes for program participants as of March 31, 2020 have been disrupted. Accordingly, we have adjusted revenue and the related unbilled receivables recorded in prior periods. During the three months ended March 31, 2020, we recorded adjustments of approximately $24 million to revenue from changes in estimates to our welfare-to-work contracts. This reduced our net income and diluted earnings per share by approximately $18 million and $0.28, respectively.
•Many of our contracts in the United States are cost-plus contracts, where we are reimbursed for costs that are allowable, allocable and reasonable. Due to the COVID-19 pandemic, we are incurring incremental and unusual costs, including additional sick pay and idle labor for employees who are unable to perform services due to their health issues, child care issues or physical restrictions imposed on their workplace. Although the U.S. Federal Government, which provides the majority of our cost-plus contracts, has provided regular guidance, there is some uncertainty within other contracts as to recoverable costs.

Changes in financial reporting
Leases
Effective October 1, 2019, we adopted ASU No. 2016-02, Leases (Topic 842). The new standard requires that assets and liabilities arising under leases be recognized on the balance sheet, except for those with an initial term of less than 12 months. We adopted this standard using a modified retrospective approach. Accordingly, we did not recast prior period financial information. Certain elections were made in adopting the standard.
•We elected to use the package of practical expedients which, among other things, allows us to not reassess historical lease classification.
•We do not separate lease and non-lease components for all classes of leases, which allows us to account for a lease as a single component.
•We used the optional transition method, which did not require us to recast our comparative periods.
•We did not use the hindsight practical expedients, which would have allowed us to use hindsight in determining the reasonably certain lease term.
•We did not adjust our accounting for leases with an initial term of twelve months or less.

Upon adopting Topic 842, we recognized a lease liability of $214.5 million, reflecting the present value of the future remaining minimum lease payments. Changes to our opening balance sheet are summarized below. There was no cumulative impact to our retained earnings and the changes did not cause any material changes in our statements of operations or our statements of cash flows. The adoption of Topic 842 does not affect our compliance with our existing contracts, including our credit facility.
(dollars in thousands) Balance at September 30, 2019 Adjustments due to adoption of new standard Opening balance at October 1, 2019
Assets
Prepaid expenses and other current assets $ 62,481    $ (6,131)   $ 56,350   
Operating lease right-of-use assets —    206,314    206,314   
Liabilities and shareholders' equity
Accounts payable and accrued expenses 177,786    (5,250)   172,536   
Operating lease liabilities —    88,276    88,276   
Other current liabilities 12,709    (648)   12,061   
Operating lease liabilities, net of current portion —    126,197    126,197   
Other long-term liabilities 20,082    (8,392)   11,690   

At the adoption of Topic 842, the Company recognized deferred tax assets and liabilities corresponding to the operating lease liabilities and operating right-of-use assets, respectively. These balances offset each other and no net effect resulted from this change.
8

Additional information and disclosures relating to this change are included within "Note 3. Leases."
Forthcoming changes
In August 2018, the Financial Accounting Standards Board (FASB) issued ASU No. 2018-15, Intangibles - Goodwill and Other - Internal-Use Software (Subtopic 350-40) - Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract. This accounting guidance requires customers in cloud-computing arrangements to identify and defer certain implementation costs in a manner broadly consistent with that of existing guidance on the costs to develop or obtain internal-use software. We will adopt this guidance on October 1, 2020. We may adopt this guidance using either a prospective or retrospective methodology. We are currently assessing the future impact of this update on our consolidated financial statements and related disclosures.
In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments. This update introduces a new model for recognizing credit losses on financial instruments, including losses on accounts receivable. We will adopt this guidance on October 1, 2020 and any changes will be recorded as a cumulative adjustment to retained earnings. We are currently assessing the future impact of this update on our consolidated financial statements and related disclosures.
In January 2017, the FASB issued ASU No. 2017-04, Simplifying the Test for Goodwill Impairment. This standard will not change the manner in which we would identify a goodwill impairment but would change any subsequent calculation of an impairment charge. We will adopt this guidance on October 1, 2020. The effect of this new standard will depend upon the outcome of future goodwill impairment tests.
Other recent accounting pronouncements are not expected to have a material effect on our financial statements.

2. Segment Information
The table below provides certain financial information for each of our business segments. We operate our business through three segments.
•Our U.S. Health and Human Services Segment provides a variety of business process services such as program administration, appeals and assessments services, and related consulting work for U.S. state and local government programs. These services support a variety of programs including the Affordable Care Act (ACA), Medicaid and the Children’s Health Insurance Program (CHIP). We also serve as administrators in state-based welfare-to-work and child support programs.
•Our U.S. Federal Services Segment provides business process solutions, including program administration, appeals and assessment services, as well as system and software development and maintenance services for various U.S. federal civilian programs. This segment also contains certain state-based assessments and appeals work that is part of the segment's heritage within the Medicare Appeals portfolio and continues to be managed within this segment.
•Our Outside the U.S. Segment provides business process solutions for governments and commercial clients outside the U.S., including health and disability assessments, program administration and case management for employment services and other work-support programs. We deliver services in the United Kingdom, including the Health Assessment Advisory Service (HAAS), the Work & Health Programme and Fair Start; Australia, including jobactive and the Disability Employment Service; Canada, including Health Insurance British Columbia and the Employment Program of British Columbia; Italy, Saudi Arabia and Singapore.

9

  Three Months Ended March 31, Six Months Ended March 31,
(dollars in thousands) 2020 % (1) 2019 % (1) 2020 % (1) 2019 % (1)
Revenue:        
U.S. Health & Human Services $ 308,698    $ 290,737    $ 620,979    $ 584,950   
U.S. Federal Services 393,391    289,736    759,962    506,723   
Outside the U.S. 116,046    156,047    255,423    309,466   
Total $ 818,135    $ 736,520    $ 1,636,364    $ 1,401,139   
Gross profit:        
U.S. Health & Human Services $ 85,454    27.7% $ 86,260    29.7% $ 175,044    28.2% $ 174,291    29.8%
U.S. Federal Services 76,958    19.6% 60,696    20.9% 147,779    19.4% 108,681    21.4%
Outside the U.S. (9,314)   (8.0)% 22,466    14.4% 5,725    2.2% 45,715    14.8%
Total $ 153,098    18.7% $ 169,422    23.0% $ 328,548    20.1% $ 328,687    23.5%
Selling, general & administrative expense:        
U.S. Health & Human Services $ 39,239    12.7% $ 29,400    10.1% $ 70,637    11.4% $ 61,539    10.5%
U.S. Federal Services 46,726    11.9% 31,104    10.7% 85,965    11.3% 57,736    11.4%
Outside the U.S. 17,404    15.0% 17,992    11.5% 33,457    13.1% 36,800    11.9%
Other (2) 3,484    NM (394)   NM 4,021    NM 1,698    NM
Total $ 106,853    13.1% $ 78,102    10.6% $ 194,080    11.9% $ 157,773    11.3%
Operating income:        
U.S. Health & Human Services $ 46,215    15.0% $ 56,860    19.6% $ 104,407    16.8% $ 112,752    19.3%
U.S. Federal Services 30,232    7.7% 29,592    10.2% 61,814    8.1% 50,945    10.1%
Outside the U.S. (26,718)   (23.0)% 4,474    2.9% (27,732)   (10.9)% 8,915    2.9%
Amortization of intangible assets (8,934)   NM (9,519)   NM (18,022)   NM (14,977)   NM
Other (3,484)   NM 394    NM (4,021)   NM (1,698)   NM
Total $ 37,311    4.6% $ 81,801    11.1% $ 116,446    7.1% $ 155,937    11.1%
(1) Percentage of respective segment revenue. Percentages not considered meaningful are marked “NM.”
(2) Other selling, general and administrative expenses includes credits and costs that are not allocated to a particular segment, including the costs for actual and potential acquisitions of other businesses.

Identifiable assets for the segments are shown below (in thousands):
March 31, 2020 September 30, 2019
U.S. Health & Human Services $ 580,487    $ 500,641   
U.S. Federal Services 939,824    795,553   
Outside the U.S. 210,095    234,769   
Corporate 230,000    214,769   
Total $ 1,960,406    $ 1,745,732   





10

3. Leases

Beginning October 1, 2019, we identify contracts which are, or contain, leases where a contract allows us the right to control identified property or equipment for a period of time in return for consideration. Our leases are typically for office space or facilities, as well as some equipment leases. Where contracts include both lease and non-lease components, we do not typically separate the non-lease components in our accounting.
At the inception of a lease, we recognize a liability for future minimum lease payments based upon the present value of those payments.
•In identifying our future minimum lease payments, we do not include variable lease costs, such as those for maintenance or utilities. These are recorded as lease expenses in the period in which they are incurred.
•In identifying future lease payments, we do not include short-term leases, identified as those with an initial term of twelve months or less.
•Lease options are included within our lease liability only where it is reasonably certain that we will utilize those periods of the lease and incur the related costs.
•In calculating the fair value of our lease liability, we utilize an estimate of our collateralized incremental borrowing rate. This estimate is based upon publicly-available information adjusted for company-specific, country-specific and lease-specific factors. The weighted average incremental borrowing rate utilized at March 31, 2020, is 3.7%.
Over the course of a lease, the lease liability is reduced as scheduled lease payments are made and increased as the implied interest charges are added.
Our right-of-use asset is based upon the lease liability at the contract inception but is adjusted over the life of the lease by lease prepayments, additional costs or lease incentives. The right-of-use asset is amortized on a straight-line basis over the lease term, offset by the interest accretion recorded on the lease liability.
Lease expense is recorded within our consolidated statements of operations based upon the nature of the assets. Where assets are used to directly serve our customers, such as facilities dedicated to customer contracts, lease costs are recorded in "cost of revenue." Facilities and assets which serve management and support functions are expensed through "selling, general and administrative expenses." Costs recorded in the three and six months ended March 31, 2020, are summarized below.
(dollars in thousands) Three Months Ended March 31, 2020 Six Months Ended March 31, 2020
Operating lease cost $ 23,437    $ 48,687   
Short-term lease cost 1,454    3,564   
Variable lease cost 1,954    5,288   
Total operating lease costs $ 26,845    $ 57,539   

Future minimum lease payments for noncancelable operating leases as of March 31, 2020 are shown below.
(dollars in thousands) Office space Equipment Total
For the years ended September 30,
Remainder of 2020 $ 42,136    $ 3,832    $ 45,968   
2021 60,372    6,295    66,667   
2022 39,752    2,353    42,105   
2023 26,490    98    26,588   
2024 11,193    40    11,233   
Thereafter 6,989    —    6,989   
Total minimum lease payments $ 186,932    $ 12,618    $ 199,550   
Less imputed interest (11,183)   (372)   (11,555)  
Total lease liabilities $ 175,749    $ 12,246    $ 187,995   

11

Our weighted average remaining lease term at March 31, 2020 is 3.0 years.
For the six months ended March 31, 2020, we made cash payments of $55.9 million for amounts included in our lease liabilities. New or amended leases resulted in additional right-of-use assets of $24.7 million.

4. Revenue Recognition

We recognize revenue as, or when, we satisfy performance obligations under a contract. The majority of our contracts have performance obligations which are satisfied over time. In most cases, we view our performance obligations as promises to transfer a series of distinct services to our customer that are substantially the same and which have the same pattern of service. We recognize revenue over the performance period as a customer receives the benefits of our services.
Disaggregation of revenue
In addition to our segment reporting, we disaggregate our revenues by service, contract type, customer type and geography. Our operating segments represent the manner in which our Chief Executive Officer reviews our financial results which is further discussed in "Note 2. Segment information."
By operating segment and service
Three Months Ended March 31, Six Months Ended March 31,
(dollars in thousands) 2020 2019 2020 2019
Program administration $ 236,436    $ 219,732    $ 473,343    $ 438,705   
Assessments and appeals 29,916    33,331    63,747    70,552   
Workforce and children services 28,734    23,898    58,120    47,801   
Other 13,612    13,776    25,769    27,892   
Total U.S. Health and Human Services $ 308,698    $ 290,737    $ 620,979    $ 584,950   
Program administration $ 304,367    $ 209,996    $ 586,055    $ 350,117   
Technology solutions 44,508    37,993    88,114    76,876   
Assessments and appeals 44,516    41,747    85,793    79,730   
Total U.S. Federal Services $ 393,391    $ 289,736    $ 759,962    $ 506,723   
Workforce and children services $ 34,683    $ 69,759    $ 91,922    $ 143,037   
Assessments and appeals 62,286    67,771    124,929    130,081   
Program administration 16,945    15,922    34,039    31,242   
Other 2,132    2,595    4,533    5,106   
Total Outside the U.S. $ 116,046    $ 156,047    $ 255,423    $ 309,466   
Total revenue $ 818,135    $ 736,520    $ 1,636,364    $ 1,401,139   

By contract type
Three Months Ended March 31, Six Months Ended March 31,
(dollars in thousands) 2020 2019 2020 2019
Performance-based $ 275,669    $ 261,592    $ 568,427    $ 574,479   
Cost-plus 398,973    298,133    761,784    473,431   
Fixed price 100,504    139,871    219,720    287,022   
Time and materials 42,989    36,924    86,433    66,207   
Total revenue $ 818,135    $ 736,520    $ 1,636,364    $ 1,401,139   
12


By customer type
Three Months Ended March 31, Six Months Ended March 31,
(dollars in thousands) 2020 2019 2020 2019
New York State government agencies $ 100,222    $ 89,858    $ 197,445    $ 181,570   
Other U.S. state government agencies 217,195    197,870    427,081    396,772   
Total U.S. state government agencies 317,417    287,728    624,526    578,342   
United States Federal Government agencies 374,909    270,623    726,742    468,901   
International government agencies 107,460    146,292    238,276    289,073   
Other, including local municipalities and commercial customers 18,349    31,877    46,820    64,823   
Total revenue $ 818,135    $ 736,520    $ 1,636,364    $ 1,401,139   

By geography
Three Months Ended March 31, Six Months Ended March 31,
(dollars in thousands) 2020 2019 2020 2019
United States of America $ 702,089    $ 580,473    $ 1,380,941    $ 1,091,673   
United Kingdom 63,722    78,334    136,724    151,752   
Australia 24,540    50,997    61,975    104,370   
Rest of world 27,784    26,716    56,724    53,344   
Total revenue $ 818,135    $ 736,520    $ 1,636,364    $ 1,401,139   

Contract balances
Differences in timing between revenue recognition and cash collection result in contract assets and contract liabilities. We classify these assets as accounts receivable — billed and billable and unbilled receivables; the liabilities are classified as deferred revenue.
In many contracts, we bill our customers on a monthly basis shortly after the month end for work performed in that month. Funds are considered collectible and are included within accounts receivable — billed and billable.
Exceptions to this pattern will arise for various reasons, including those listed below.
•Under cost-plus contracts, we are typically required to estimate a contract’s share of our general and administrative expenses. This share is based upon estimates of total costs which may vary over time. We typically invoice our customers at an agreed provisional billing rate which may differ from actual rates incurred. If our actual rates are higher than the provisional billing rates, an asset is recorded for this variance; if the provisional billing rates are higher than our actual rates, we record a liability.
•Certain contracts include retainage balances, whereby revenue is earned but cash payments are held back by the customer for a period of time, typically to allow the customer to confirm the objective criteria laid out by the contract have been met. This balance is classified as accounts receivable - unbilled until restrictions on billing have been lifted.
•In certain contracts, we may receive funds from our customers prior to performing operations. These funds are typically referred to as “set-up costs” and reflect the need for us to make investments in infrastructure prior to providing a service. This investment in infrastructure is not a performance obligation which is distinct from the service that is subsequently provided and, as a result, revenue is not recognized based upon the
13

establishment of this infrastructure, but rather over the course of the contractual relationship. The funds are initially recorded as deferred revenue and recognized over the term of the contract. Other contracts may not include set-up fees but will provide higher fees in earlier periods of the contract. The premium on these fees is deferred.
•Some of our contracts, notably our welfare-to-work contracts in the Outside the U.S. Segment, include payments for outcomes, such as job retention, which occur over several months. We are required to estimate these outcome fees ahead of their realization and recognize this estimated fee over the period of delivery.
Of our revenue for the three and the six months ended March 31, 2020, approximately $22.1 million and $40.1 million were from cash payments made to us prior to October 1, 2019. For the three and six months ended March 31, 2019, we recognized revenue of $10.2 million and $32.0 million from payments made prior to October 1, 2018.
Contract estimates
We are required to use estimates in recognizing revenue from some of our contracts. As discussed in "Note 1. Organization and Basis of Presentation", the calculation of these estimates has been complicated by the COVID-19 pandemic, which has reduced our ability to use past results to estimate future performance.
Some of our performance-based contract revenue is recognized based upon future outcomes defined in each contract. This is the case in many of our welfare-to-work contracts in the Outside the U.S. Segment, where we are paid as individuals attain employment goals, which may take many months to achieve. We recognize revenue on these contracts over the period of performance. Our estimates vary from contract to contract but may include estimates of the number of participants, the length of the contract and the participants reaching employment milestones. We are required to estimate these outcome fees ahead of their realization and recognize this estimated fee over the period of delivery. In almost all of the jurisdictions in which we operate, the employment markets have experienced significant changes due to the COVID-19 pandemic. For our existing program participants, many employment opportunities have been terminated or are no longer available. Our volume of new program participants is expected to increase but it is unclear as to when these populations will be in a position to seek employment in many industries which have been curtailed by the COVID-19 pandemic. In some cases, we anticipate that we may be unable to place individuals in employment in the short-term.
Other performance-based contracts with future outcomes include those where we recognize an average effective rate per participant based upon the total volume of expected participants. In this instance, we are required to estimate the amount of discount applied to determine the average rate of revenue per participant. Our revised estimates of participant numbers are based upon our updated evaluation of probable future volumes. We are required to use estimates in recognizing certain revenue.
Where we have changes to our estimates, these are recognized on a cumulative catch-up basis. In the three and six months ended March 31, 2020, we reported reductions in revenue of $6.3 million and $7.7 million from changes in estimates as of September 30, 2019. In the three and six months ended March 31, 2019, we reported reductions in revenue of $6.5 million and $8.0 million, respectively, from changes in estimates.
Deferred contract costs
For many contracts, we incur significant incremental costs at the beginning of an arrangement. Typically, these costs relate to the establishment of infrastructure which we utilize to satisfy our performance obligations with the contract. We report these costs as deferred contract costs and amortize them on a straight-line basis over the shorter of the useful economic life of the asset or the anticipated term of the contract.
Three Months Ended March 31, Six Months Ended March 31,
(dollars in thousands) 2020 2019 2020 2019
Deferred contract cost capitalization $ 2,666    $ 5,113    $ 3,995    $ 8,212   
Deferred contract cost amortization 1,321    1,478 3,497    2,820
This amortization was recorded within our "cost of revenue" on our consolidated statements of operations.
14

Remaining performance obligations
At March 31, 2020, we had approximately $270 million of remaining performance obligations. We anticipate that we will recognize revenue on approximately 55% of this balance within the next 12 months. This balance excludes contracts with an original duration of twelve months or less, including contracts with a penalty-free termination for convenience clause, and any variable consideration which is allocated entirely to future performance obligations including variable transaction fees or fees tied directly to costs incurred.

5. Earnings Per Share
The weighted average number of shares outstanding used to compute earnings per share was as follows:
  Three Months Ended March 31, Six Months Ended March 31,
(shares in thousands) 2020 2019 2020 2019
Basic weighted average shares outstanding 63,934    64,369    64,264    64,600   
Dilutive effect of unvested RSUs 191    274    182    217   
Denominator for diluted earnings per share 64,125    64,643    64,446    64,817   

Our dilutive earnings per share for the three and six months ended March 31, 2020, excludes any effect from approximately 280,000 and 250,000 unvested restricted stock units, respectively, as adding them to our calculation would have been antidilutive. There were no antidilutive awards in the three and six months ended March 31, 2019.

6. Acquisitions
On November 16, 2018, we acquired General Dynamics Information Technology's citizen engagement centers business for $430.7 million. This acquisition strengthens our position in the administration of federal government programs and the business was integrated into our U.S. Federal Services Segment. We completed our allocation of the purchase price to the assets acquired and liabilities assumed in September 2019, including goodwill of $184.6 million and intangible assets of $122.3 million.
On August 16, 2019, we acquired 100% of the share capital of GT Hiring Solutions (2005) Inc. (GT Hiring) for $6.2 million (8.2 million Canadian Dollars). GT Hiring provides employment services in British Columbia. We acquired GT Hiring to enhance the reach and capabilities of our Canadian employment services and, accordingly, the business has been integrated into our Outside the U.S. Segment. We are still in the process of finalizing the allocation of assets acquired and liabilities assumed. We recorded estimated goodwill and intangible assets balances of $1.5 million and $2.7 million, respectively, related to this acquisition. The goodwill represents the assembled workforce and enhanced knowledge, experience and reputation we have obtained from the acquisition and will be deductible for tax purposes. The intangible assets represent customer relationships, which will be amortized over seven years.
On February 28, 2020, we acquired 100% of the share capital of InjuryNet Australia Pty Limited (InjuryNet) for an estimated purchase price of $3.7 million (5.6 million Australian Dollars). The purchase price is subject to adjustment for a working capital true-up. InjuryNet provides workplace medical services in Australia. The business has been integrated into our Outside the U.S. Segment. We are still in the process of finalizing allocation of assets acquired and liabilities assumed.

7. Supplemental Disclosures
Under a resolution adopted in March 2020, the Board of Directors authorized the purchase, at management's discretion, of up to $200 million of our common stock. This supplemented a similar resolution adopted in June 2018. During the six months ended March 31, 2020, we purchased approximately 2,767,000 of our common shares at a cost of $167.0 million. During the six months ended March 31, 2019, we acquired approximately 716,000 common shares at a cost of $45.4 million. At March 31, 2020, $150.0 million remained available for future stock purchases.
During the six months ended March 31, 2020, we granted 316,000 restricted stock units to our board of directors and employees. These awards will vest ratably over one and five years, respectively.
15

Our deferred compensation plan uses both mutual fund and life insurance investments to fund its obligations. The mutual funds are recorded at fair value, based upon quoted prices in active markets, and the life insurance investments at cash surrender value; changes in value are reported in our consolidated statements of operations. At March 31, 2020, the deferred compensation plan held $18.4 million of the mutual fund investments.
The carrying amounts of cash and cash equivalents, accounts receivable, accounts payable and other amounts included within current assets and liabilities that meet the definition of a financial instrument are shown at values equivalent to fair value due to the short-term nature of these items. Our debt balances are principally from credit facilities which can be utilized and repaid as required and whose rates are based upon prevailing market conditions; accordingly, we believe the balance disclosed is consistent with fair value. Our accounts receivable billed and billable balance includes both amounts invoiced and amounts that are ready to be invoiced where the funds are collectible within standard invoice terms. Our accounts receivable unbilled balance includes balances where revenue has been earned but no invoice was issued on or before March 31, 2020. Restricted cash represents funds which are held in our bank accounts but which we are precluded from using for general business needs through contractual requirements; these requirements include serving as collateral for lease, credit card or letter of credit arrangements or where we hold funds on behalf of clients. Restricted cash is included within "prepaid expenses and other assets" on our balance sheet and is included within "cash, cash equivalents and restricted cash" in our consolidated statements of cash flows. A reconciliation of these balances is shown below.
  Balance as of
(dollars in thousands) March 30,
2020 		September 30, 2019 March 31,
2019 		September 30, 2018
Cash and cash equivalents $ 126,257    $ 105,565    $ 46,799    $ 349,245   
Restricted cash (recorded within "other current assets") 12,485    10,927    7,679    7,314   
Cash, cash equivalents and restricted cash 138,742    116,492    54,478    356,559   

During the six months ended March 31, 2020 and 2019, we made interest payments of $0.5 million and $1.8 million, respectively.
During the six months ended March 31, 2020 and 2019, we made income tax payments of $52.9 million and $37.2 million, respectively.

8. Litigation
We are subject to audits, investigations and reviews relating to compliance with the laws and regulations that govern our role as a contractor to agencies and departments of the United States Federal Government, state, local and foreign governments, and otherwise in connection with performing services in countries outside of the U.S. Adverse findings could lead to criminal, civil or administrative proceedings, and we could be faced with penalties, fines, suspension or debarment. Adverse findings could also have a material adverse effect on us because of our reliance on government contracts. We are subject to periodic audits by federal, state, local and foreign governments for taxes. We are also involved in various claims, arbitrations and lawsuits arising in the normal conduct of our business. These include but are not limited to bid protests, employment matters, contractual disputes and charges before administrative agencies. Although we can give no assurance, based upon our evaluation and taking into account the advice of legal counsel, we do not believe that the outcome of any existing matter would likely have a material adverse effect on our consolidated financial position, results of operations or cash flows.
Medicaid claims
The Centers for Medicare and Medicaid Services (CMS) has asserted two disallowances against a state Medicaid agency totaling approximately $31 million. From 2004 through 2009, we had a contract with the state agency in support of its school-based Medicaid claims. We entered into separate agreements with the school districts under which we assisted the districts with preparing and submitting claims to the state Medicaid agency which, in turn, submitted claims for reimbursement to CMS. The state has asserted that its agreement with us requires us to reimburse the state for the amounts owed to CMS. However, our agreements with the school districts require them to reimburse us for such amounts, and therefore we believe the school districts are responsible for any amounts that ultimately must be refunded to CMS. Although it is reasonably possible that a court could conclude we are responsible for the full balance of the disallowances, we believe our exposure in this matter is limited to our fees
16

associated with this work and that the school districts will be responsible for the remainder. We have reserved our estimated fees earned from this engagement relating to the disallowances. We exited the federal healthcare-claiming business in 2009 and no longer provide the services at issue in this matter. The state contested the first disallowance of approximately $12 million in U.S. District Court. In February 2020, the District Court upheld that disallowance, and the state has appealed the case to the U.S. Circuit Court of Appeals. The second disallowance of approximately $19 million is still pending at the U.S. Health and Human Services Departmental Appeals Board. No legal action has been initiated against us with respect to either disallowance.

9. Subsequent Events
On April 3, 2020, our Board of Directors declared a quarterly cash dividend of $0.28 for each share of our common stock outstanding. The dividend is payable on May 29, 2020, to shareholders of record on May 15, 2020. Based upon the number of shares outstanding, we anticipate a cash payment of approximately $17 million.
On May 1, 2020, we sold a subsidiary that holds a contract that we were required to divest to avoid a conflict resulting from a new contract. The purchase price was $3.25 million.

17

Item 2.                   Management’s Discussion and Analysis of Financial Condition and Results of Operations.
The following discussion and analysis of financial condition and results of operations is provided to enhance the understanding of, and should be read in conjunction with, our Consolidated Financial Statements and related Notes included both herein and in our Annual Report on Form 10-K for the year ended September 30, 2019, which was filed with the Securities and Exchange Commission on November 26, 2019.

Business Overview
We are a leading operator of government health and human services programs worldwide. We are a responsible and reliable contracting partner to governments under our mission of Helping Government Serve the People®. Governments rely on our financial stability and proven expertise in helping people connect and use critical government programs. We use our experience, business process management expertise, innovation and technology solutions to help government agencies run effective, efficient and accountable programs.
Our primary portfolio of work is tied to business process services (BPS) in the health services and human services markets. Our growth over the last decade was driven by new work, such as that from the Affordable Care Act (ACA) in the United States and a growing footprint in clinical services including assessments, appeals and independent medical reviews in multiple geographies, as well as acquisitions in the United States and 
United Kingdom.
COVID-19 pandemic
We have been and continue to be negatively affected by the COVID-19 pandemic. The dynamic nature of the circumstances increases the difficulty of predicting the scale of disruption from COVID-19 or how deep and severe the economic consequences will be. Accordingly, the full impact of the COVID-19 pandemic is uncertain. Continued business disruption relating to the COVID-19 pandemic may, among other things, negatively impact demand for our services, our workforce availability, our ability to perform fully on our contracts and our costs and may also limit the ability of customers to make timely payments to us, all of which would adversely affect our business, financial position, results of operations and cash flows.
We continue to serve our clients but have been subject to the social distancing, stay-at-home and other restrictions imposed by national, state and local governments. Our challenge has been to find methods of maintaining continuity of operations, including strict security standards, until social distancing requirements are relaxed.
We anticipate that we will be able to return to our previous levels of performance once the effect of this pandemic abates. However, the timing of this is uncertain and may vary by contract and location.
•We have strong relationships with our clients, with many considering us to be providing “essential services” to ensure that vital government programs continue to operate and that citizens continue to receive critical assistance at a time when the need for healthcare and safety-net programs is rising. Where we cannot provide services in the short-term, some of our clients are exploring ways of maintaining our services on a cost-recovery basis until pandemic restrictions are lifted.
•We have a strong customer base. Within the United States, many of the services we provide are either directly for the U.S. Federal Government or are mandated by the U.S. Federal Government. Outside the United States, our services are often provided for or funded by national governments. Although we may experience some delays in payments as governments navigate new processes to make payments, we expect to continue to receive payments.
•At March 31, 2020, we had $126.3 million of cash and $150 million of borrowings on our credit facility, leaving $250 million of available capacity. We believe we have adequate cash resources and credit availability to handle our obligations as they fall due.
•In the long-term, we believe that many of the demographic and legislative trends that we have articulated as opportunities for the growth of our business will continue. With societies continuing to see increased longevity and more complex health needs coupled with a desire by governments to spend wisely and seek outcome-based services, we believe we remain well-placed to build on our existing relationships and reputation.
18

We use a well-trained workforce to perform our operations. In order to preserve their safety and security, we have implemented a number of steps to ensure social distancing and the reduction of risk to our workforce. Where possible, employees are encouraged to work from home. Where this is not possible, workplaces are enforcing screening, social distancing and regular cleaning and sanitizing. We have introduced a number of leave and income protection for employees who experience COVID-19 related absences.
Acquisitions
To supplement our core business, we have an active program to identify potential strategic acquisitions. Our acquisitions have successfully enabled us to increase future organic growth, as well as expand our business processes, knowledge and client relationships into adjacent markets and new geographies. In November 2018, we acquired the citizen engagement centers business previously operated by General Dynamics Information Technology. This acquisition, coupled with our 2015 acquisition of Acentia, LLC, has provided increased scale, customer base and competitive advantages in our business with the United States Federal Government. In August 2019 and February 2020, we acquired GT Hiring Solutions in Canada and InjuryNet in Australia, respectively, which we have integrated into our Outside the U.S. Segment. These acquisitions supplement our existing businesses in this segment.
We have paused significant acquisition activity until we see an easing of the uncertainties resulting from the COVID-19 pandemic. We continue to work on smaller tuck-in transactions that will support future organic growth in a meaningful way.

Financial Overview
The COVID-19 pandemic has affected each of our segments in different ways and at different times. Although all of the jurisdictions in which we operate followed different paths in reacting to the pandemic, the broad approach of restricting travel, cancelling large social gatherings, closing non-essential services and issuing restrictions on daily living developed during the three months ended March 31, 2020. Accordingly, our results for the three and six months ended March 31, 2020, were affected by the pandemic towards the end of the period. The effects of the pandemic have continued into our third fiscal quarter. The effect on our financial statements in this period was different across each of our segments.
•We experienced limited disruption within our U.S. Health & Human Services and U.S. Federal Services Segments as we worked to maintain our operations, while prioritizing the safety of our employees. We anticipate some continued disruption in these segments over the next two fiscal quarters from incremental costs due to idle labor, enhanced screening and enhanced cleaning but we do not anticipate significant changes within our contract base.
•Our Outside the U.S. Segment received an immediate and significant negative impact from the pandemic as a significant portion of our international work is employment related, whether in finding work for individuals or assessing their health and work capabilities. The changes in the employment markets in these jurisdictions has sharply reduced the number of individuals in work and the number of employment opportunities available to them, resulting in a sharp decline in our outcome-based revenue. This segment was also affected to a lesser extent by the Australian bushfires in December 2019 and January 2020.
•The nature of the COVID-19 pandemic makes projections more challenging than is typically the case. We have made assumptions for the remainder of the fiscal year based upon our expectations of how the restrictions imposed by the pandemic will be eased and are dependent upon how quickly the economies of the jurisdictions in which we operate will recover.
19


Results of Operations
Consolidated
The following table sets forth, for the periods indicated, selected statements of operations data:
  Three Months Ended March 31, Six Months Ended March 31,
(dollars in thousands, except per share data) 2020 2019 2020 2019
Revenue $ 818,135    $ 736,520    $ 1,636,364    $ 1,401,139   
Cost of revenue 665,037    567,098    1,307,816    1,072,452   
Gross profit 153,098    169,422    328,548    328,687   
Gross profit percentage 18.7  % 23.0  % 20.1  % 23.5  %
Selling, general and administrative expenses 106,853    78,102    194,080    157,773   
Selling, general and administrative expense as a percentage of revenue 13.1  % 10.6  % 11.9  % 11.3  %
Amortization of intangible assets 8,934    9,519    18,022    14,977   
Operating income 37,311    81,801    116,446    155,937   
Operating margin 4.6  % 11.1  % 7.1  % 11.1  %
Interest expense 465    1,569    949    2,194   
Other income, net 573    447    1,292    2,492   
Income before income taxes 37,419    80,679    116,789    156,235   
Provision for income taxes 9,769    18,913    30,405    38,746   
Effective income tax rate 26.1  % 23.4  % 26.0  % 24.8  %
Net income 27,650    61,766    86,384    117,489   
Loss attributable to noncontrolling interests —    (158)   —    (348)  
Net income attributable to MAXIMUS $ 27,650    $ 61,924    $ 86,384    $ 117,837   
Basic earnings per share $ 0.43    $ 0.96    $ 1.34    $ 1.82   
Diluted earnings per share $ 0.43    $ 0.96    $ 1.34    $ 1.82   
Our business segments have different factors driving revenue fluctuations and profitability. The sections that follow cover these segments in greater detail.
Changes in revenue, cost of revenue and gross profit for the three months ended March 31, 2020, are summarized below.
Revenue Cost of Revenue Gross Profit
(dollars in thousands) Dollars Percentage change Dollars Percentage change Dollars Percentage change
Three months ended March 31, 2019 $ 736,520    $ 567,098    $ 169,422   
Growth from citizen engagement centers contracts 84,223    11.4  % 68,345    12.1  % 15,878    9.4  %
Organic (decline)/growth from other contracts (3,978)   (0.5) % 30,873    5.4  % (34,851)   (20.6) %
Acquired growth 3,402    0.5  % 3,030    0.5  % 372    0.2  %
Currency effect compared to the prior period (2,032)   (0.3) % (4,309)   (0.8) % 2,277    1.3  %
Three months ended March 31, 2020 $ 818,135    11.1  % $ 665,037    17.3  % $ 153,098    (9.6) %

Revenue and cost of revenue for the three months ended March 31, 2020, increased compared to the same period in fiscal year 2019, principally driven by the citizen engagement centers business acquisition in the U.S. Federal Services Segment. Although this acquisition provided a full quarter of results in both periods, the Census
20

Questionnaire Assistance (CQA) contract is now approaching its peak level of operations whereas work was at an early stage in fiscal year 2019.
Our businesses within the United States experienced organic revenue growth, offset by declines within our Outside the U.S. Segment. The factors driving changes are discussed in more detail below.
Our cost of revenue includes direct costs related to labor, subcontractor labor, outside vendors, rent and other direct costs.
Changes in revenue, cost of revenue and gross profit for the six months ended March 31, 2020, are summarized below.
Revenue Cost of Revenue Gross Profit
(dollars in thousands) Dollars Percentage change Dollars Percentage change Dollars Percentage change
Six months ended March 31, 2019 $ 1,401,139    $ 1,072,452    $ 328,687   
Estimated pre-acquisition results from citizen engagement centers business 98,429    85,341    13,088   
Pro forma results for the six months ended March 31, 2019 1,499,568    1,157,793    341,775   
Growth from citizen engagement centers contracts 122,328    8.2  % 96,936    8.4  % 25,392    7.4  %
Organic growth/(decline) from other contracts 11,889    0.8  % 53,426    4.6  % (41,537)   (12.2) %
Acquired growth 6,375    0.4  % 5,582    0.5  % 793    0.2  %
Currency effect compared to the prior period (3,796)   (0.3) % (5,921)   (0.5) % 2,125    0.6  %
Six months ended March 31, 2020 $ 1,636,364    9.1  % $ 1,307,816    13.0  % $ 328,548    (3.9) %

We estimate that revenue and cost of revenue for the period from October 1, 2018 to November 16, 2018 (the acquisition date) would have increased our revenue and cost of revenue by $98.4 million and $85.3 million, respectively. We have utilized pro forma revenue, cost of revenue and gross profit in calculating the changes shown above.
Selling, general and administrative expense (SG&A) consists of indirect costs related to general management, marketing and administration. It is primarily composed of labor costs. These costs may be incurred at a segment level, for dedicated resources that are not client-facing, or at a corporate level. Corporate costs are allocated to segments on a consistent and rational basis. Fluctuations in our SG&A are primarily driven by changes in our administrative cost base, which is not directly driven by changes in our revenue. As part of our work for the United States Federal Government and many states, we allocate these costs using a methodology driven by the Federal Cost Accounting Standards.
Our SG&A expense has increased year-over-year due primarily to:
•bad debt charges of $7.8 million from an increase in receivable reserves due to payment concerns related to COVID-19 and a billing dispute with a customer;
•increases in business development activity to both bolster our technical skills and plan for increased bidding activity;
•increases in our scope of operations, particularly related to the CQA contract in the U.S. Federal Services Segment and
•higher than usual specific acquisition costs and IT transformation initiatives, including migrating our existing data centers to the cloud.
21

Amortization of intangible assets received a full charge from our acquisition of the citizen engagement centers business during fiscal year 2020. Additional charges from the acquisition of GT Hiring Solutions and InjuryNet also increased our amortization expense.
Our interest expense is primarily driven by borrowings from our credit facility. During fiscal year 2020, we drew on our credit facility to cover our working capital requirements. In fiscal year 2019, we borrowed $150.0 million to partially fund the acquisition of the citizen engagement centers business; this borrowing was repaid in full before the end of fiscal year 2019.
Our effective tax rate for the three months ended March 31, 2020, was 26.1%, compared to 23.4% in the same period in fiscal year 2019. We are closely monitoring the effects of changes in tax legislation, notably the United States CARES Act, which provides for some tax credits and delayed payment of some taxes. The effect on our results in the three and six months ended March 31, 2020 was not material.
U.S. Health & Human Services Segment
Our U.S. Health and Human Services Segment provides a variety of business process services such as program administration, appeals and assessments services, and related consulting work for U.S. state and local government programs. These services support a variety of programs including the Affordable Care Act (ACA), Medicaid and the Children’s Health Insurance Program (CHIP). We also serve as administrators in state-based welfare-to-work and child support programs.
  Three Months Ended March 31, Six Months Ended March 31,
(dollars in thousands) 2020 2019 2020 2019
Revenue $ 308,698    $ 290,737    $ 620,979    $ 584,950   
Cost of revenue 223,244    204,477    445,935    410,659   
Gross profit 85,454    86,260    175,044    174,291   
Operating income 46,215    56,860    104,407    112,752   
Gross profit percentage 27.7  % 29.7  % 28.2  % 29.8  %
Operating income percentage 15.0  % 19.6  % 16.8  % 19.3  %

Our revenue and cost of revenue for the three month period ended March 31, 2020, increased 6.2% and 9.2%, respectively, compared to the same period in fiscal year 2019. For the six months ended March 31, 2020, growth was 6.2% and 8.6%, respectively. All growth was organic.
Revenue growth was driven by new contracts and the expansion of existing contracts. Our gross profit was negatively impacted by approximately $9 million by a single, large contract where we performed work prior to the contract being executed. This contract amendment was signed in April 2020 and, accordingly, will benefit our third fiscal quarter. Our operating profit was negatively impacted by the bad debt charges of $7.1 million.
This segment experienced disruption, resulting in declines in profit margins, from the impact of the COVID-19 pandemic in the last three weeks of March 2020. The disruption was not uniform as each U.S. state and locality imposed different requirements on our working practices and operations. Some locations were temporarily closed through local requirements driven by COVID-19.
Many of the services we provide are considered essential and, accordingly, our customers are working with us to ensure continuity of service. We have experienced and expect to continue to experience some disruption in the short term as we change our manner of operating, whether due to a need for additional space to allow for social distancing or through the costs of working from remote locations. This has resulted in some reduced revenue, as we are unable to operate at full efficiency. The effect on each contract varies based upon the requirements imposed by the client or the jurisdiction and the manner in which we are reimbursed for services. In some locations, we have taken on additional work associated with unemployment insurance, which will partially offset some of these losses. We anticipate our operating income margins will be between 17% and 18% for the full fiscal year.
Our customers in this segment are typically U.S. state governments, who have seen increases in the demand for the social services that we administer while also experiencing a significant reduction in their tax revenues. Although this may provide additional opportunities for us, we face the risk that many of our customers may face cash shortfalls from reduced income tax receipts, resulting in a need to delay payments.
22

U.S. Federal Services Segment
Our U.S. Federal Services Segment provides business process solutions, including program administration, appeals and assessment services as well as system and software development and maintenance services for various U.S. federal civilian programs. This segment also contains certain state-based assessments and appeals work that is part of the segment's heritage within the Medicare Appeals portfolio and continues to be managed within this segment.
  Three Months Ended March 31, Six Months Ended March 31,
(dollars in thousands) 2020 2019 2020 2019
Revenue $ 393,391    $ 289,736    $ 759,962    $ 506,723   
Cost of revenue 316,433    229,040    612,183    398,042   
Gross profit 76,958    60,696    147,779    108,681   
Operating income 30,232    29,592    61,814    50,945   
Gross profit percentage 19.6  % 20.9  % 19.4  % 21.4  %
Operating income percentage 7.7  % 10.2  % 8.1  % 10.1  %

Changes in revenue, cost of revenue and gross profit for the three months ended March 31, 2020, are summarized below.
Revenue Cost of Revenue Gross Profit
(dollars in thousands) Dollars Percentage change Dollars Percentage change Dollars Percentage change
Three months ended March 31, 2019 $ 289,736    $ 229,040    $ 60,696   
Growth from citizen engagement centers contracts 84,223    29.1  % 68,345    29.8  % 15,878    26.2  %
Organic growth from other contracts 19,432    6.7  % 19,048    8.3  % 384    0.6  %
Three months ended March 31, 2020 $ 393,391    35.8  % $ 316,433    38.2  % $ 76,958    26.8  %

Changes in revenue, cost of revenue and gross profit for the six months ended March 31, 2020, are summarized below.
Revenue Cost of Revenue Gross Profit
(dollars in thousands) Dollars Percentage change Dollars Percentage change Dollars Percentage change
Six months ended March 31, 2019 (1) $ 506,723    $ 398,042    $ 108,681   
Estimated pre-acquisition results from citizen engagement centers business (2) 98,429    85,341    13,088   
Pro forma results for the six months ended March 31, 2019 605,152    483,383    121,769   
Growth from citizen engagement centers contracts (3) 122,328    20.2  % 96,936    20.1  % 25,392    20.9  %
Organic growth from other contracts (4) 32,482    5.4  % 31,864    6.6  % 618    0.5  %
Three months ended March 31, 2020 $ 759,962    25.6  % $ 612,183    26.6  % $ 147,779    21.4  %

23

To show the changes between the six months ended March 31, 2019 and 2020, we utilized the following information.
1.These balances represent our results for the six months ended March 31, 2019. These results include approximately six weeks of benefit from the citizen engagement centers business, which was acquired on November 16, 2018 (the acquisition date).
2.These balances represent an estimate of the results for the citizen engagement centers business for the pre-acquisition period – the period from October 1, 2018 through to the acquisition date. This balance, combined with our prior year results, provides pro forma results – an estimate of the results of this segment if we had acquired the citizen engagement centers business on or before October 1, 2018.
3.These balances represent the growth, on a pro forma basis, of the contracts acquired with the citizen engagement centers business from the first two quarters of fiscal years 2019 to the first two quarters of fiscal year 2020. The principal driver of this growth was the Census Questionnaire Assistance (CQA) contract.
4.These balances represent the growth reported between the first two quarters of fiscal years 2019 and 2020 of existing contracts outside those acquired.
The majority of revenue in this segment is generated by cost-plus contracts, including almost all of the income acquired from the citizen engagement centers business. Accordingly, we are able to recover COVID-19-related costs incurred on these contracts. Our revenue has increased as a result of new and acquired contracts but margins tempered by additional costs on some performance-based arrangements and ongoing investments in business development.
The CQA contract had $185 million of revenue in fiscal year 2019. The contract contributed approximately $210 million of revenue in the first half of fiscal year 2020 and is anticipated to provide approximately $430 - $450 million of revenue during the current fiscal year.
While we have experienced some disruption from the COVID-19 pandemic, we believe that the nature of our contracts and the desires of our customers will allow us to continue operating, albeit with some restrictions. We anticipate operating profit margins for the remainder of the year will be between 8% and 9%.
Outside the United States Segment
Our Outside the U.S. Segment provides business process solutions for governments and commercial clients outside the U.S., including health and disability assessments, program administration and case management for employment services and other work-support programs. We deliver services in the United Kingdom, including the Health Assessment Advisory Service (HAAS), the Work & Health Programme and Fair Start; Australia, including jobactive and the Disability Employment Service; Canada, including Health Insurance British Columbia and the Employment Program of British Columbia; Italy, Saudi Arabia and Singapore.
  Three Months Ended March 31, Six Months Ended March 31,
(dollars in thousands) 2020 2019 2020 2019
Revenue $ 116,046    $ 156,047    $ 255,423    $ 309,466   
Cost of revenue 125,360    133,581    249,698    263,751   
Gross (loss)/profit (9,314)   22,466    5,725    45,715   
Operating (loss)/income (26,718)   4,474    (27,732)   8,915   
Gross profit percentage (8.0) % 14.4  % 2.2  % 14.8  %
Operating income percentage (23.0) % 2.9  % (10.9) % 2.9  %
24


Changes in revenue, cost of revenue and gross profit for the three months ended March 31, 2020, are summarized below.
Revenue Cost of Revenue Gross Profit
 (dollars in thousands) Dollars Percentage change Dollars Percentage change Dollars Percentage change
Three months ended March 31, 2019 $ 156,047    $ 133,581    $ 22,466   
Organic decline (41,371)   (26.5) % (6,942)   (5.2) % (34,429)   (153.2) %
Acquired growth 3,402    2.2  % 3,030    2.3  % 372    1.7  %
Currency effect compared to the prior period (2,032)   (1.3) % (4,309)   (3.2) % 2,277    10.1  %
Three months ended March 31, 2020 $ 116,046    (25.6) % $ 125,360    (6.2) % $ (9,314)   (141.5) %

Changes in revenue, cost of revenue and gross profit for the six months ended March 31, 2020, are summarized below.
Revenue Cost of Revenue Gross Profit
 (dollars in thousands) Dollars Percentage change Dollars Percentage change Dollars Percentage change
Six months ended March 31, 2019 $ 309,466    $ 263,751    $ 45,715   
Organic decline (56,622)   (18.3) % (13,714)   (5.2) % (42,908)   (93.9) %
Acquired growth 6,375    2.1  % 5,582    2.1  % 793    1.7  %
Currency effect compared to the prior period (3,796)   (1.2) % (5,921)   (2.2) % 2,125    4.6  %
Six months ended March 31, 2020 $ 255,423    (17.5) % 249,698    (5.3) % 5,725    (87.5) %


The COVID-19 pandemic has had an immediate and significant negative effect on the results of our Outside the U.S. Segment. This business has several significant contracts that are compensated based upon performance-based outcomes, which have been significantly disrupted by the COVID-19 pandemic.
Our welfare-to-work contracts earn revenue based upon our ability to place individuals in long-term sustained employment. Revenue is recognized based on our estimate of the number of individuals who we anticipate reaching these milestones. As a result of the pandemic, we revised our estimates of those jobseekers who are likely to achieve employment outcomes. In March 2020, we have recorded a decline in our estimated outcomes of approximately $24 million. Although we are continuing to service participants in these programs where we can, the pool of available employment opportunities is significantly lower than before.
Our health assessment contracts, including HAAS, have experienced declines in volumes as our ability to provide face-to-face assessments and the demand for occupational health services has diminished. As a temporary measure, we have furloughed some employees and a number of medical professionals in the United Kingdom have volunteered to assist the National Health Service. In the latter case, payments made to our employees will be on a pass through basis and will not result in revenue or profit. Our revenues will be significantly reduced until the conditions caused by the pandemic have eased.
As a result of this disruption, we anticipate that we will continue to experience operating losses for the remainder of this fiscal year. Within the U.K., we are in the process of transitioning some of our contracts to a cost-recovery model. In the longer-term, we anticipate an expanded need for our services across all geographies as we help our customers to expand and adapt their employment programs to cope with widespread unemployment.
Our acquired growth is from the acquisition of GT Hiring Solutions in Canada in August 2019 and InjuryNet in Australia in February 2020.
25

The continued strength of the United States Dollar against the currencies in which we do business outside the U.S. has resulted in year-over-year declines in our revenue and costs.

The Outside the U.S. Segment performs a significant part of its operations in the United Kingdom. As such, we are closely monitoring developments following the departure of the United Kingdom from the European Union. We do not anticipate the withdrawal to have a material direct effect on our business in the United Kingdom due to the nature of our customer base and the absence of cross-border operations. However, the uncertainty over the process has affected us indirectly. We anticipate we will continue to be subject to political risks, as legislative priorities may change and economic risks from the post-withdrawal environment.
Liquidity and Capital Resources
The COVID-19 pandemic has negatively affected our cash flows in March 2020 as there are some contracts where we were unable to perform at full level of operations or where payments are outcome-based. At March 31, 2020, we had approximately $126 million in unrestricted cash and $250 million of liquidity available on our credit facility. Our cash and cash equivalents balance included $36.5 million held in foreign locations in local currencies. While we expect a reduction to revenues due to the COVID-19 pandemic, we believe that we will have positive free cash flow for the second half of fiscal year 2020.
Governments worldwide have introduced a number of short-term policies to assist businesses with their liquidity. We anticipate utilizing payroll credits in the United States and the United Kingdom, as well as the deferral of certain tax obligations in the United States. We have also furloughed approximately 200 employees in the United Kingdom.
Our international locations have access to borrowing facilities which they may use to cover short-term working capital needs or small acquisitions, such as our acquisitions of GT Hiring Solutions and InjuryNet.
We have no requirement to remit funds from our foreign locations back to the United States. With the passage of the Tax Cuts and Jobs Act in the United States, we are able to transfer a significant amount of funds from our foreign locations on a tax-free basis. We will continue to explore opportunities to bring back additional funds, taking into consideration the working capital requirements and relevant tax rules in each jurisdiction. When we are unable to remit funds back without incurring a penalty, we will consider these funds indefinitely reinvested until such time as these restrictions are changed. As a result, we do not record U.S. deferred income taxes on any funds held in foreign jurisdictions. We have not attempted to calculate our potential liability from any transfer of these funds as any such transaction might include tax planning strategies which we have not fully explored. Accordingly, it is not possible to estimate the potential tax obligations if we were to remit all of our funds from foreign locations to the United States.
Cash Flows
The following table provides a summary of our cash flow information for the six months ended March 31, 2020 and 2019.
  Six Months Ended March 31,
(dollars in thousands) 2020 2019
Net cash provided by/(used in):    
Operations $ 109,272    $ 127,211   
Investing activities (21,575)   (420,070)  
Financing activities (63,579)   (8,590)  
Effect of exchange rate changes on cash and cash equivalents (1,868)   (632)  
Net increase/(decrease) in cash, cash equivalents and restricted cash $ 22,250    $ (302,081)  

Our cash flows from operations were reduced compared to fiscal year 2019 due to the declines in our operating income and the timing of our cash payments. These were partially offset by improvements in our cash collections.
•Our income tax payments for the six months ended March 31, 2020 were $52.9 million, compared to $37.2 million in fiscal year 2019. We anticipate that our tax payments for the second half of the year will be lower than our provision for income taxes.
26

•Our Days Sales Outstanding (DSO) at March 31, 2020 were 72 days; the balance at September 30, 2019, was also 72 days. We have a target range for DSO of 65 to 80 days and in recent years, we have typically maintained the lower end of this range. We anticipate our DSO may grow during the remainder of the fiscal year as U.S. state governments may delay payments to assist their cash flows.
Cash used in investing activities for the six months ended March 31, 2020, was $21.6 million, principally for capital expenditures to support operations.
Cash used in financing activities in the six months ended March 31, 2020, was $63.6 million, compared to $8.6 million of cash provided in the comparative period. Fiscal year 2020 included $167.0 million of purchases of common stock, partially offset by $150.5 million of net borrowings. Credit facility borrowings and stock purchase transactions were less significant in fiscal year 2019.
To supplement our statements of cash flows presented on a GAAP basis, we use the measure of free cash flow to analyze the funds generated from operations.
  Six Months Ended March 31,
(dollars in thousands) 2020 2019
Cash flows from operations $ 109,272    $ 127,211   
Purchases of property and equipment and capitalized software costs (19,122)   (18,541)  
Capital expenditure as a result of acquisition (1) —    4,542   
Free cash flow - non-gaap $ 90,150    $ 113,212   
(1) Purchases of property and equipment and capitalized software costs included $4.5 million in one time payments to cover software licenses required for employees joining us through the citizen engagement centers acquisition in November 2018.

Critical Accounting Policies and Estimates
Our discussion and analysis of our financial condition and results of operations are based on our consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States. The preparation of these financial statements requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent liabilities, and the reported amounts of revenue and expenses. On an ongoing basis we evaluate our estimates, including those related to revenue recognition and cost estimation on certain contracts, the realizability of goodwill and other long-lived assets, and amounts related to contingencies and income tax liabilities. We base our estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities. Actual results could differ from those estimates.
During the six months ended March 31, 2020, we made changes to the manner in which we record leases. For additional information, please see "Note 3. Leases" in our "Notes to Unaudited Consolidated Financial Statements" in Item 1 of this Form 10-Q.

Non-GAAP Measures
We utilize non-GAAP measures where we believe it will assist the user of our financial statements in understanding our business. The presentation of these measures is meant to complement, but not replace, other financial measures in this document. The presentation of non-GAAP numbers is not meant to be considered in isolation, nor as an alternative to revenue growth, cash flows from operations or net income as measures of performance. These non-GAAP measures, as determined and presented by us, may not be comparable to related or similarly titled measures presented by other companies.
In fiscal year 2019, 21% of our revenue was generated outside the U.S. We believe that users of our financial statements wish to understand the performance of our foreign operations using a methodology which excludes the effect of year-over-year exchange rate fluctuations. To calculate year-over-year currency movement, we determine the current fiscal year’s results for all foreign businesses using the exchange rates in the prior fiscal year. We refer to this adjusted revenue on a "constant currency basis."
27

In recent years, we have made a number of acquisitions. We believe users of our financial statements wish to evaluate the performance of our operations, excluding changes that have arisen due to businesses acquired. Where information is available, we will show pro forma revenue, cost of revenue and gross profit. Pro forma results represent an estimate of the results of the business as though we had owned the business for an entire comparative period, rather than just a portion of it. To provide pro forma financial information, we use the results of the acquired business as prepared by the former owners adjusted to reflect changes in accounting and eliminating transactions between ourselves and the company. Where this information has not been prepared, we will identify acquired revenue and cost of revenue by showing these results for periods for which no comparative results exist within our financial statements. We provide pro forma comparative results and acquired revenue as a way of allowing investors to see the growth in our business on a year-over-year basis. This information is supplemented by our calculations of organic revenue. To calculate organic revenue growth, we compare current fiscal year revenue excluding revenue from these acquisitions to our prior fiscal year revenue.
In order to sustain our cash flows from operations, we require regular refreshing of our fixed assets and technology. We believe that users of our financial statements wish to understand the cash flows that directly correspond with our operations and the investments we must make in those operations using a methodology which combines operating cash flows and capital expenditures. We provide free cash flow to complement our statement of cash flows. Free cash flow shows the effects of the Company’s operations and replacement capital expenditures and excludes the cash flow effects of acquisitions, purchases of our own common stock, dividend payments and other financing transactions. We have provided a reconciliation of free cash flow to cash provided by operations.
To sustain our operations, our principal source of financing comes from receiving payments from our customers. We believe that users of our financial statements wish to evaluate our efficiency in converting revenue into cash receipts. Accordingly, we provide DSO, which we calculate by dividing billed and unbilled receivable balances at the end of each quarter by revenue per day for the period. Revenue per day for a quarter is determined by dividing total revenue by 91 days.
As noted above, we have a $400 million credit facility. Our credit agreement includes the defined term Consolidated EBITDA and our calculation of Adjusted EBITDA conforms to the credit agreement definition. We believe our investors appreciate the opportunity to understand the possible restrictions which arise from our credit agreement. Adjusted EBITDA is also a useful measure of performance which focuses on the cash generating capacity of the business as it excludes the non-cash expenses of depreciation and amortization, and makes for easier comparisons between the operating performance of companies with different capital structures by excluding interest expense and therefore the impacts of financing costs. The measure of Adjusted EBITA is a step in calculating Adjusted EBITDA and facilitates comparisons to similar businesses as it isolates the amortization effect of business combinations. Our credit facility requires us to calculate Adjusted EBITDA on a pro forma basis as though we had owned any acquired business for a full twelve month period prior to the acquisition. We have provided a reconciliation from net income to Adjusted EBITA, Adjusted EBITDA and Pro Forma Adjusted EBITDA as follows:
  Six Months Ended
March 31, 		Trailing Twelve Months Ended
March 31,
(dollars in thousands) 2020 2019 2020 2019
Net income attributable to MAXIMUS $ 86,384    $ 117,837    $ 209,371    $ 224,005   
Interest (income)/expense, net (80)   79    (442)   (1,612)  
Provision of income taxes 30,405    38,746    68,484    79,839   
Amortization of intangible assets 18,022    14,977    36,099    19,964   
Stock compensation expense 11,800    9,904    22,670    18,818   
Acquisition-related expenses 3,377    2,850    4,400    3,797   
Adjusted EBITA - non-gaap $ 149,908    $ 184,393    $ 340,582    $ 344,811   
Depreciation and amortization of property, plant, equipment and capitalized software 31,218    22,407    61,215    47,217   
Adjusted EBITDA - non-gaap $ 181,126    $ 206,800    $ 401,797    $ 392,028   
Additional adjusted EBITDA related to citizen engagement centers acquisition 6,695    16,158   
Pro Forma Adjusted EBITDA - non-gaap $ 213,495    $ 408,186   

28

Item 3.                   Quantitative and Qualitative Disclosures about Market Risk.
Our exposure to market risks generally relates to changes in foreign currency exchange rates.
At March 31, 2020, and September 30, 2019, we held net assets denominated in currencies other than the U.S. Dollar of $161.1 million and $176.3 million, respectively. Of these balances, cash and cash equivalents comprised $36.5 million and $18.9 million, respectively. Accordingly, in the event of a 10% unfavorable exchange rate movement across these currencies, we would have reported the following incremental effects on our comprehensive income and our cash flow statement (in thousands).
  March 31, 2020 September 30, 2019
Comprehensive income attributable to MAXIMUS $ (16,114)   $ (17,630)  
Net decrease in cash and cash equivalents (3,649)   (1,890)  
Included within our net assets held in international currency are assets which we consider to be monetary assets — those which hold a fair value close to their book value and which represent a recent cash outflow or which will become a cash inflow or outflow within a short period of time. These assets and liabilities are typically cash, billed, billable and unbilled accounts receivable, current prepaid expenses, accounts payable, accrued compensation, deferred revenue and debt. At March 31, 2020, the net value of these assets and liabilities was $55.4 million.
Where possible, we identify surplus funds in foreign locations and place them into entities with the U.S. Dollar as their functional currency. This mitigates our exposure to foreign currencies. We mitigate our foreign currency exchange risks within our operating divisions through incurring costs and cash outflows in the same currency as our revenue.
We are exposed to interest rate risk through our revolving credit facility and other short term borrowings. Our interest rate for the revolving credit facility is based upon the one-month London Interbank Offering Rate (LIBOR) or equivalent plus a premium based upon our leverage; this premium is currently 1%. The one-month LIBOR at March 31, 2020, was approximately 0.99%. We had borrowings of $150.0 million under the facility at March 31, 2020. Accordingly, an increase of 1% in interest rates would result in an annualized additional expense of $1.5 million. The balance of our outstanding debt at March 31, 2020, was comprised of short-term borrowings in foreign locations to cover short-term working capital needs. The terms and rates under which we borrow in these jurisdictions varies from location to location. As these borrowings are relatively small and for brief periods, we do not anticipate significant interest rate exposure. In the event that longer-term borrowings were required or if the costs of borrowing became expensive, we would anticipate using our current cash balance to cover these obligations.

Item 4.                   Controls and Procedures.
(a)   Evaluation of Disclosure Controls and Procedures
Our management, with the participation of our principal executive officer and principal financial officer, has evaluated the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) as of the end of the period covered by this Quarterly Report on Form 10-Q. Based on this evaluation, our principal executive officer and principal financial officer concluded that these disclosure controls and procedures were effective and designed to ensure that the information required to be disclosed in our reports filed or submitted under the Exchange Act is recorded, processed, summarized and reported within the time periods specified by the Securities and Exchange Commission’s rules and forms, and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosure.
(b)    Changes in Internal Control over Financial Reporting
There was no change in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) identified in connection with the evaluation of our internal control that occurred during our last fiscal quarter that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

29

PART II.  OTHER INFORMATION
 
Item 1.              Legal Proceedings.
We are subject to audits, investigations and reviews relating to compliance with the laws and regulations that govern our role as a contractor to agencies and departments of the United States Federal Government, state, local and foreign governments, and otherwise in connection with performing services in countries outside of the U.S. Adverse findings could lead to criminal, civil or administrative proceedings, and we could be faced with penalties, fines, suspension or debarment. Adverse findings could also have a material adverse effect on us because of our reliance on government contracts. We are subject to periodic audits by federal, state, local and foreign governments for taxes. We are also involved in various claims, arbitrations and lawsuits arising in the normal conduct of our business. These include but are not limited to bid protests, employment matters, contractual disputes and charges before administrative agencies. Although we can give no assurance, based upon our evaluation and taking into account the advice of legal counsel, we do not believe that the outcome of any existing matter would likely have a material adverse effect on our consolidated financial position, results of operations or cash flows.
Medicaid claims
The Centers for Medicare and Medicaid Services (CMS) has asserted two disallowances against a state Medicaid agency totaling approximately $31 million. From 2004 through 2009, we had a contract with the state agency in support of its school-based Medicaid claims. We entered into separate agreements with the school districts under which we assisted the districts with preparing and submitting claims to the state Medicaid agency which, in turn, submitted claims for reimbursement to CMS. The state has asserted that its agreement with us requires us to reimburse the state for the amounts owed to CMS. However, our agreements with the school districts require them to reimburse us for such amounts, and therefore we believe the school districts are responsible for any amounts that ultimately must be refunded to CMS. Although it is reasonably possible that a court could conclude we are responsible for the full balance of the disallowances, we believe our exposure in this matter is limited to our fees associated with this work and that the school districts will be responsible for the remainder. We have reserved our estimated fees earned from this engagement relating to the disallowances. We exited the federal healthcare-claiming business in 2009 and no longer provide the services at issue in this matter. The state contested the first disallowance of approximately $12 million in U.S. District Court. In February 2020, the District Court upheld that disallowance, and the state has appealed the case to the U.S. Circuit Court of Appeals. The second disallowance of approximately $19 million is still pending at the U.S. Health and Human Services Departmental Appeals Board. No legal action has been initiated against us with respect to either disallowance.

Item 1A.              Risk Factors.
In connection with information set forth in this Form 10-Q, the factors discussed below and under “Risk Factors” in our Form 10-K for fiscal year ended September 30, 2019, should be considered. The risks included below and in the Form 10-K could materially and adversely affect our business, financial condition and results of operations.
Other than as set forth below, there have been no material changes to the factors discussed in our Annual Report on Form 10-K for the year ended September 30, 2019, which was filed with the Securities and Exchange Commission on November 26, 2019.
Our business could be materially and adversely impacted by the recent coronavirus (“COVID-19”) outbreak or other similar outbreaks.

We face various risks related to health epidemics, pandemics and similar outbreaks, including the recent global outbreak of the novel coronavirus disease (“COVID-19”). COVID-19 is negatively impacting worldwide economic activity and has resulted in travel and work restrictions, commercial disruptions and has affected companies' operations around the world. We have been and continue to be affected by the COVID-19 pandemic, including through office closures and changes in working practices. If significant portions of our workforce are unable to work effectively, including because of illness, quarantines, government actions, facility closures or other restrictions in connection with the COVID-19 pandemic, our operations will likely be adversely impacted. If our operations are materially restricted, we may be unable to perform fully on our contracts and our costs may increase as a result of the COVID-19 outbreak. These cost increases may not be fully recoverable or adequately covered by insurance.
We have also experienced procurement delays, increased labor and technology costs and reductions in outcome-based contract revenue. If these conditions are more protracted or severe than anticipated, it could have a
30

material effect on our business, cause delays or limit the ability of our customers to perform, including in making timely payments to us.
In recent months, the spread of COVID-19 has led to disruption and volatility in the global capital markets, which increases the cost of capital and could impede our ability to access capital, if we need to do so in the future.
We continue to work with our customers, employees and suppliers to address responsibly this global pandemic. We will continue to monitor the situation and assess further possible implications to our business and our stakeholders and will take appropriate actions in an effort to mitigate adverse consequences. We cannot assure you that we will be successful in any such mitigation efforts.
Our customers, and therefore our business and revenues, are sensitive to negative changes in general economic conditions. In particular, many governments will be anticipating reduced income from taxes as a result of the COVID-19 pandemic. Any continued or further decline in economic conditions, as a result of COVID-19 or otherwise, would negatively impact our business.
We cannot at this time predict the impact of the COVID-19 pandemic and any resulting economic impact, but it could have a material adverse effect on our business, financial position, results of operations and cash flows.

Item 2.              Unregistered Sales of Equity Securities and Use of Proceeds.
(c) The following table sets forth the information required regarding purchases of common stock that we made during the three months ended March 31, 2020.
Period Total
Number of
Shares
Purchased 		Average
Price Paid
per Share 		Total Number of
Shares Purchased as
Part of Publicly
Announced Plans(1) 		Approximate Dollar
Value of Shares that
May Yet Be
Purchased
Under the Plan
(in thousands)
January 1, 2020 - January 31, 2020 20,000    $ 72.48    20,000    $ 142,696   
February 1, 2020 - February 29, 2020 451,700    67.04    451,700    112,416   
March 1, 2020 - March 31, 2020 2,269,246    58.72    2,269,246    150,026   
Total 2,740,946    2,740,946     
______________________________________________
(1)Under a resolution adopted in March 2020, the Board of Directors authorized the purchase, at management's discretion, of up to an aggregate of $200 million of our common stock. The resolution also authorized the use of option exercise proceeds for the purchase of our common stock. This replaced a similar resolution adopted in June 2018. On March 25, 2020, we announced that we have suspended share repurchases under this authorization. We will re-evaluate the share repurchase program once there is clarity around the impact of the COVID-19 pandemic on our business.
31

Item 6.                       Exhibits.
Exhibit No.   Description
3.1 s
31.1 s
31.2 s
32.1 v
32.2 v
101 The following materials from the MAXIMUS, Inc. Quarterly Report on Form 10-Q for the quarter ended March 31, 2020 formatted in eXtensible Business Reporting Language (XBRL): (i) Consolidated Statements of Operations, (ii) Consolidated Statements of Comprehensive Income, (iii) Consolidated Balance Sheets, (iv) Consolidated Statements of Cash Flows, (v) Consolidated Statements of Changes in Shareholders’ Equity and (vi) Notes to Consolidated Financial Statements. Filed electronically herewith.
104 Cover Page Interactive Data File (formatted as Inline XBRL tags and contained in Exhibit 101)
_____________________________________________________
s Filed herewith.
v Furnished herewith.

32

SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
  MAXIMUS, INC.
Date: May 7, 2020 By: /s/ Richard J. Nadeau
    Richard J. Nadeau
    Chief Financial Officer
    (On behalf of the registrant and as Principal Financial and Accounting Officer)

33

Exhibit 3.1

MAXIMUS, INC.

ARTICLES OF AMENDMENT
OF
AMENDED AND RESTATED
ARTICLES OF INCORPORATION

Pursuant to Section 13.1-710 of the Virginia Stock Corporation Act under Title 13.1, Chapter 9 of the Code of Virginia, the undersigned, on behalf of the corporation set forth below, states as follows:

1.The name of the Corporation is MAXIMUS, Inc.

2.Sections 2 and 3 of Article SEVENTH of the Amended and Restated Articles of Incorporation of the Corporation (the “Articles of Incorporation”) are hereby deleted and replaced with the following:

“2. Until the 2023 annual meeting of Shareholders, the directors shall be divided into three classes, as nearly equal in number as the then total number of directors constituting the entire Board permits. At the 2021 annual meeting of Shareholders, the directors who shall be elected at the 2021 annual meeting to fill the directorships held by directors whose terms expire at the 2021 annual meeting shall be elected for one-year terms expiring at the 2022 annual meeting of Shareholders; at the 2022 annual meeting of Shareholders, the directors who shall be elected at the 2022 annual meeting to fill the directorships held by directors whose terms expire at the 2022 annual meeting shall be elected for one-year terms expiring at the 2023 annual meeting of Shareholders; at the 2023 annual meeting of Shareholders, the terms of all directors shall expire and at such annual meeting and at each annual meeting thereafter, all directors shall be elected for one-year terms expiring at the next annual meeting of Shareholders. From and after the 2023 annual meeting of Shareholders, the directors shall no longer be divided into classes.
3. Each director chosen to fill a vacancy in the Board of Directors shall be elected to complete the term of office of the director who is being succeeded. In the case of any election of a new director to fill a directorship created by an enlargement of the Board, such director shall hold office for a term expiring at the next meeting of Shareholders at which directors are elected.”

3.This amendment was adopted by the Corporation on March 17, 2020.

4.The Board of Directors found that this amendment was in the best interests of the Corporation and directed that it be submitted to shareholders in accordance with the provisions of Title 13.1, Chapter 9 of the Code of Virginia. The shareholders duly approved this amendment in the manner required by Title 13.1, Chapter 9 of the Code of Virginia and the Articles of Incorporation at its annual meeting of shareholders on March 17, 2020.


The undersigned General Counsel and Secretary of the Corporation declares that the facts herein stated are true as of March 17, 2020.


MAXIMUS, Inc.
By: /s/ David R. Francis
Name: David R. Francis
Title: General Counsel and Secretary
SCC ID# 01616614


EXHIBIT 31.1
Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
I, Bruce L. Caswell, certify that:
1. I have reviewed this Quarterly Report on Form 10-Q of MAXIMUS, Inc. for the period ended March 31, 2020;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
Date: May 7, 2020  
    /s/ Bruce L. Caswell
    Bruce L. Caswell
    Chief Executive Officer



EXHIBIT 31.2
Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
I, Richard J. Nadeau, certify that:
1. I have reviewed this Quarterly Report on Form 10-Q of MAXIMUS, Inc. for the period ended March 31, 2020;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
Date: May 7, 2020  
    /s/ Richard J. Nadeau
    Richard J. Nadeau
    Chief Financial Officer



EXHIBIT 32.1
Section 906 CEO Certification
I, Bruce L. Caswell, Chief Executive Officer of MAXIMUS, Inc. (“the Company”), do hereby certify, under the standards set forth in and solely for the purposes of 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:
1. The Quarterly Report on Form 10-Q of the Company for the period ended March 31, 2020 (the “Quarterly Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. Section 78m or 78o(d)) and
2. The information contained in the Quarterly Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: May 7, 2020  
    /s/ Bruce L. Caswell
    Bruce L. Caswell
    Chief Executive Officer



EXHIBIT 32.2
Section 906 CFO Certification
I, Richard J. Nadeau, Chief Financial Officer of MAXIMUS, Inc. (“the Company”), do hereby certify, under the standards set forth in and solely for the purposes of 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:
1. The Quarterly Report on Form 10-Q of the Company for the period ended March 31, 2020 (the “Quarterly Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. Section 78m or 78o(d)) and
2. The information contained in the Quarterly Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: May 7, 2020  
    /s/ Richard J. Nadeau
    Richard J. Nadeau
    Chief Financial Officer